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Abstract 
Crucial to a cell’s ability to migrate is the organization of its plasma membrane 
and associated proteins in a polarized manner to interact with and respond to its 
surrounding environment.  Cells interact with the extracellular matrix (ECM) through 
specialized contact sites, including podosomes and invadopodia.  Tumor cells use 
F-actin-rich invadopodia to degrade ECM and invade tissues; related structures, termed 
podosomes, are sites of dynamic ECM interaction and degradation.  We show here that 
supervillin (SV), a peripheral membrane protein that binds F-actin and myosin II, 
reorganizes the actin cytoskeleton and potentiates invadopodial function.  Overexpressed 
SV increases the number of F-actin punctae, which are highly dynamic and co-localize 
with markers of podosomes and invadopodia.  Endogenous SV localizes to the cores of 
Src-generated podosomes in COS-7 cells and with invadopodia in MDA-MB-231 cells.  
EGFP-SV overexpression increases the average amount of matrix degradation; RNAi-
mediated downregulation of SV decreases degradation. Cortactin, an essential component 
of both podosomes and invadopodia, binds SV sequences in vitro and contributes to the 
formation of EGFP-SV induced punctae.   Additionally, SV affects cortactin localization, 
which could provide a mechanism for SV action at invadopodia.   
The formation of cholesterol-rich membrane rafts is one method of plasma 
membrane organization.  A property of membrane rafts is resistance to extraction with 
cold Triton X-100 and subsequent flotation to low buoyant densities.  The actin 
cytoskeleton has been implicated in many signaling events localized to membrane rafts, 
but interactions between actin and raft components are not well characterized.  Our 
laboratory isolated a heavy detergent resistant membrane fraction from neutrophils, 
 vii 
called DRM-H, that contains at least 23 plasma membrane proteins.  DRM-H is rich in 
cytoskeletal proteins, including fodrin, actin, myosin II, as well as supervillin.  DRM-H 
also contains proteins implicated in both raft organization and membrane-mediated 
signaling.  DRM-H complexes exhibit a higher buoyant density than do most DRMs 
(referred to as DRM-L), which are deficient in cytoskeletal proteins.  By using similar 
purification methods, I find that COS-7 cells also contain cytoskeleton-associated DRMs.  
In addition, when transfected into COS-7 cells, estrogen receptor (ER)α associates with 
DRM-H, while ERβ is seen in both DRM-L and DRM-H populations, suggesting a role 
for DRM-H in nongenomic estrogen signaling.  Thus, the cytoskeleton-associated DRM-
H not limited to hematopoietic cells and could constitute a scaffold for membrane raft-
cytoskeleton signaling events in many cells. 
Taken together, our results show that SV is a component of cytoskeleton-
associated membrane rafts as well as podosomes and invadopodia, and that SV plays a 
role in invadopodial function.  SV, with its connections to both membrane rafts and the 
cytoskeleton, is well situated to mediate cortactin localization, activation state, and/or 
dynamics of matrix metalloproteases at the ventral cell surface for proper matrix 
degradation through invadopodia.  The molecular dissection of invadopodia formation 
and function may contribute to a greater understanding of in vivo invasion, and thus, 
tumor cell metastasis.   
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Chapter I 
General Introduction 
Adhesion, motility and invasion are three basic cell biological properties that are 
necessary steps in a wide variety of fundamental biological processes.  Motility underlies 
virtually every stage of progression of a single cell to a multicellular organism, during 
development, from the mass migration of cells during gastrulation, to the formation of 
blood vessels. These processes also play key roles in maintenance of health, including 
tissue repair and immunological defense against pathogens. In order to recognize foreign 
substances, immune cells undergo invasive cell movement to reach sites of infection and 
adhere to antigen presenting cells.  Adhesion, motility and invasion also contribute to 
disease states such as cancer cell metastasis. In order to metastasize, primary tumor cells 
must lose adhesion to detach from neighboring cells, increase motility and invasion to 
intravasate to blood vessels, travel in the circulatory system or the lymph, then 
extravasate into and colonize a secondary tissue.   
Cell motility involves several distinct steps (Lauffenburger and Horwitz, 1996; 
Ridley et al., 2003).  Cells initiate migration by polarization of plasma membrane and 
cytoskeletal components to form membrane protrusions, including lamellipodia and 
filopodia.  Cells then form attachments at their leading edge to stabilize protrusions, 
primarily through integrin transmembrane receptors which couple the extracellular matrix 
(ECM) to the actin cytoskeleton on the inside of the cell (Geiger et al., 2001; Wehrle-
Haller and Imhof, 2002).  Myosin-based contractility is required to translocate the cell 
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body forward, followed by detachment of adhesions at the rear of the cell (Broussard et 
al., 2008).   
Crucial to a cell’s ability to migrate is the organization of plasma membrane and 
associated proteins in a polarized manner to interact with and respond to their 
surrounding environment.  For many years, the fluid mosaic model, where proteins float 
in a sea of lipids, was the textbook view of the plasma membrane (Singer and Nicolson, 
1972).  This view has been challenged by the appreciation of a more ordered phase of the 
plasma membrane, referred to as lipid rafts, or, more precisely, membrane rafts. 
Membrane rafts are defined as “small (10-200 nm), heterogeneous, highly dynamic, 
sterol- and/or sphingolipid-enriched domains that compartmentalize cellular processes.  
Small rafts can sometimes be stabilized to form larger platforms through protein-protein 
and protein-lipid interactions” (Pike, 2006).  Membrane rafts are distributed 
asymmetrically during migration in many cell types and may be a mechanism for proper 
distribution of membrane receptors, including chemosensory receptors and ECM 
interacting proteins (Gomez-Mouton et al., 2001; Seveau et al., 2001; Manes et al., 
2003).  These membrane domains serve to organize lipids and proteins for a variety of 
signal cascades and trafficking events (Simons and Toomre, 2000; Echarri et al., 2007).  
Additionally, there is a role for the underlying cytoskeleton in organization of membrane 
domains (Holowka et al., 2000; Viola and Gupta, 2007).  Kusumi and colleagues have 
proposed a picket fence model of membrane organization. Diffusion of membrane 
proteins and lipids is limited by the membrane skeleton meshwork (fence) as well as 
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transmembrane proteins anchored to the meshwork (pickets), and proteins and lipids 
“hop” from one zone to the next (Kusumi et al., 2005). 
Formation of ECM contacts also contributes to cell polarity and motility.  The 
most studied cell-ECM contact site, typically found in fibroblasts, is the focal adhesion: 
large, relatively stable, integrin based adhesion structures located at the ends of stress 
fiber bundles (Wehrle-Haller and Imhof, 2003; Zaidel-Bar et al., 2004).  In addition to 
focal adhesions, cells interact with the ECM via other actin-rich structures, termed 
podosomes and invadopodia.  Podosomes and invadopodia contain many focal adhesion 
molecules, but are quite distinct in appearance and function (Block et al., 2008). 
Although podosomes are similar to invadopodia and the terms are sometimes used 
interchangeably, the current convention is to refer to structures found in normal cells and 
in Src-transformed fibroblasts as podosomes, and the structures in tumor cells as 
invadopodia (Gimona et al., 2008). 
Podosomes are highly dynamic structures that come in close contact with the 
substrate and consist of a core of F-actin surrounded by a ring of adhesion proteins, 
including integrins, vinculin and talin (Figure 1-1) (Linder and Aepfelbacher, 2003). 
Podosomes have a diameter of ~0.3 µm and a height of ~0.5 µm and are highly dynamic, 
with a half-life of 2-12 minutes (Destaing et al., 2003; Evans et al., 2003).  While some 
podosomes are formed de novo, many arise from precursor structures (Evans et al., 
2003).  The actin assembly molecules Arp2/3 and WASp/N-WASp are essential for 
podosome formation (Linder et al., 1999; Linder et al., 2000).  Src kinase activity is a 
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potent inducer of podosomes (Destaing et al., 2008), and it was in Rous sarcoma virus-
transformed fibroblasts that the “peculiar dot-like” podosomes were described early in 
the field (Marchisio et al., 1987).  Very recently, initial events in podosome formation 
have been examined in Src-transformed fibroblasts (Oikawa et al., 2008), showing that 
Src activation leads to a rapid increase in the accumulation of phosphoinositide-3,4-
bisphosphate (PI(3,4)P2), followed by recruitment of the Src substrate and protease-
binding protein Tks5 and the adaptor protein Grb2.  Tks5 contains 5 SH3 domains that 
bind to N-WASp and may thereby contribute to actin polymerization at podosomes.   
Podosomes engage in matrix remodeling and tissue invasion and thus are 
prominent in cell types that cross tissue boundaries, including cells of monocytic lineage 
(osteoclasts, macrophages and dendritic cells) (Marchisio et al., 1984; Linder et al., 1999; 
Burns et al., 2001).  Podosomes have also been detected after induction with phorbol 
esters or cytokines in smooth muscle cells and epithelial cells, respectively (Hai et al., 
2002; Osiak et al., 2005; Varon et al., 2006).  Podosomes function in bone resorption in 
osteoclasts by adhesion to the bone and subsequent formation of a sealing zone around 
the resorption pit (Inui et al., 1999; Stenbeck and Horton, 2000; Chabadel et al., 2007). 
Podosome assembly is blocked in cells from mice deficient in gelsolin, an actin severing 
and capping protein, and these mice show increased bone mass due to decreased 
osteoclast function (Chellaiah et al., 2000).  The precise function of podosomes in 
macrophages is less well defined, but podosome deficient macrophages have impaired 
adhesion and motility (Linder et al., 1999).   
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Figure 1-1.  Model of podosome organization.   
 
Ring structure detail is shown in the upper left panel.  Integrins link signaling molecules 
to the actin core via paxillin, vinculin, talin and alpha-actinin. 
 
The upper right panel shows a detailed view of the podosome core proteins.  The 
podosome core consists of a branched network of actin filaments nucleated by cdc42-
activated WASp and Arp2/3.  The central core of F-actin filaments surrounds an 
invagination of the plasma membrane.   
 
Reprinted with permission (Linder and Aepfelbacher, 2003). 
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Invadopodia are protrusive structures responsible for focalized matrix degradation 
in invasive cancer cell lines (Chen, 1989; Gimona et al., 2008).  Though related to 
podosomes by the presence of an F-actin core, they do not have such a well-defined, 
regular ring structure.  Instead, invadopodia appear as irregularly shaped F-actin punctae 
at ventral cell surfaces with associated invaginations and protrusions of the plasma 
membrane (Baldassarre et al., 2003).  Invadopodial structures can be long-lived, some 
lasting up to 2 hours (Baldassarre et al., 2006; Yamaguchi and Condeelis, 2007).  Integrin 
engagement provides the initial trigger for invadopodia formation, and plays a role in the 
docking and activation of proteases at these structures (Mueller and Chen, 1991; 
Nakahara et al., 1998; Mueller et al., 1999; Deryugina et al., 2001).  Like podosomes, 
invadopodia depend on Src kinase activity and branched actin assembly, with essential 
contributions from N-WASp, cortactin Arp2/3, AMAP1, dynamin 2, and Arf6 (Stylli et 
al., 2008).   
The observation that invadopodia are important mediators of matrix degradation 
in cultured cells may be extended to a role for such structures in vivo.  The presence of 
invadopodia in various cell lines has been correlated with other measures of metastasis 
(Coopman et al., 1998). In addition, isolated tumor cells also form invadopodia, showing 
that they are not artifacts of culture conditions (Clark et al., 2007; Stylli et al., 2008).   
Advances in intravital imaging have revealed intravasating carcinoma cells with 
invadopodia-like protrusions that penetrate blood vessel walls (Condeelis and Segall, 
2003; Yamaguchi et al., 2005b). A paracrine signaling loop has been proposed for 
cooperative tumor invasion in which carcinoma cells secrete colony stimulating factor-1 
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(CSF-1) to promote podosome formation in tumor associated macrophages, and 
macrophages secrete epidermal growth factor (EGF) to stimulate invadopodia formation 
(Yamaguchi et al., 2006).  Taken together, these data suggest that both podosomes and 
invadopodial action may be required for cancer cells to break through the basement 
membrane (Figure 1-2) (Yamaguchi et al., 2005b).   
Cortactin is necessary for both podosome and invadopodia formation and function 
(Artym et al., 2006; Webb et al., 2006a; Clark et al., 2007; Webb et al., 2007).   
Cortactin is a multidomain Src substrate that stimulates Arp2/3 induced actin 
polymerization and activation of N-WASp (Wu and Parsons, 1993; Uruno et al., 2001; 
Weaver et al., 2001). ERK phosphorylation of cortactin positively regulates its ability to 
activate N-WASp in vitro, whereas Src phosphorylation is a negative regulator 
(Martinez-Quiles et al., 2004).  Cortactin promotes cell motility, invadopodia formation 
and invasion through matrix barriers (Weaver, 2008).  Gene amplification at chromosome 
11q13, a poor prognostic indicator, frequently results in cortactin overexpression in 
breast as well as head and neck cancers (Schuuring et al., 1992; Weaver, 2008).  
Although cortactin is not suspected in tumor initiation, a dominant negative non-
phosphorylatable cortactin (Y421, 466, 482F) mutant inhibited bone metastasis in an in 
vivo mouse model (Li et al., 2001).  Thus, cortactin is an important actin regulatory 
protein involved in invasion, and possibly tumor progression.   
In an effort to understand the composition of membrane skeletons in highly motile 
cells, the Luna laboratory identified supervillin (SV) as an F-actin binding protein in 
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Figure 1-2.  Model for intravasation of cancer cells.   
Migratory carcinoma cells detach from neighboring cells and degrade the basement 
membrane through invadopodial action.  These cells travel along ECM fibers with 
stimulation from EGF secreted by tumor associated macrophages.  The tumor cells 
secrete CSF-1, thereby stimulating macrophages to form podosomes.  This results in 
cooperative invasion into the bloodstream. 
 
Reprinted with permission (Yamaguchi et al., 2005b). 
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neutrophils (Pestonjamasp et al., 1995).  SV is a tightly bound peripheral membrane 
protein with a highly conserved C-terminus with homology to the actin-reorganizing 
proteins villin and gelsolin (Pestonjamasp et al., 1997).  Thus, SV derives its name from 
being one of the largest members of the villin/gelsolin superfamily (Pestonjamasp et al., 
1997; Silacci et al., 2004; Khurana and George, 2008). Abundant levels of SV message 
have been reported in HeLa cervical adenocarcinoma, SW480 colorectal 
adenocarcinoma, and A549 lung carcinoma cells (Pope et al., 1998).  Also, more SV 
protein is present on immunoblots of whole cell lysates from HeLa cells than in lysates 
from NIH-3T3 fibroblasts, COS7 cells, or kidney epithelial cell lines (Pestonjamasp et 
al., 1997). In Madin-Darby bovine kidney (MDBK) epithelial cells, SV localizes in a 
punctate manner at the membrane and in the cytoplasm in low-density cultures, and to 
areas of cell-cell contact at higher cell density.  In addition, co-localization with the cell-
cell adhesion protein E-cadherin increased upon transition to a more confluent culture 
(Pestonjamasp et al., 1997).  
Biochemical purifications and domain analysis of SV has identified many binding 
partners.  An initial surprise resulted in the demonstration that the F-actin binding motif 
resides in the novel SV N-terminus, not as expected in the villin/gelsolin homologous 
sequences. (Wulfkuhle et al., 1999) This study also revealed functional nuclear targeting 
domains in the center of the protein (SV-830-1009) (Wulfkuhle et al., 1999).   Finer 
mapping of the SV N-terminus identified at least three F-actin binding sites, as well as 
binding sites for nonmuscle myosin II, the long form of myosin light chain kinase (L-
MLCK) and thyroid receptor-interacting protein 6 (TRIP6), a LIM-domain containing 
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focal adhesion protein (Chen et al., 2003; Takizawa et al., 2006; Takizawa et al., 2007).  
SV also co-purifies with a detergent resistant membrane fraction, called DRM-H, that 
contains ~23 neutrophil plasma membrane proteins (Nebl et al., 2002).  DRM-H is rich in 
cytoskeletal proteins, including fodrin, actin and myosins IG and II, in addition to 
membrane raft organizing proteins and signaling molecules.  Taken together, these 
interactions point to a role for SV in integrating membrane-cytoskeleton signaling events.   
In fact, SV has dramatic effects on the organization of the actin cytoskeleton and 
on focal adhesions (Wulfkuhle et al., 1999; Takizawa et al., 2006; Takizawa et al., 2007). 
Overexpression of EGFP-SV in COS7-2 cells induces a change in the distribution of 
intracellular F-actin (Wulfkuhle et al., 1999), along with decreases in the numbers of 
stress fibers and large focal adhesions (Takizawa et al., 2006).  There is an inverse 
correlation of SV levels and strength of adhesion to fibronectin-coated surfaces; SV 
overexpression decreases adhesion, whereas RNAi-mediated knockdown of SV increases 
adhesion (Takizawa et al., 2006).  A similar relationship exists regarding cell spreading.  
SV downregulation increases the rate of cell spreading and overexpression of SV slows 
spreading rates by upregulating myosin II activation at the plasma membrane (Takizawa 
et al., 2007).  An alternatively spliced form of SV, archvillin, found in skeletal muscle is 
involved in the organization of muscle costameres, and myogenic differentiation (Oh et 
al., 2003).  Smooth muscle archvillin (SmAV) is required for extracellular-signal-
regulated kinase (ERK1/2) activation and stimulus-mediated contractility (Gangopadhyay 
et al., 2004).  Thus, SV is an interesting, multifunctional molecule that serves as a 
scaffold for membrane-cytoskeleton signaling.   
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Objective of dissertation studies 
The goal of my thesis research was to unravel the cellular functions of SV, an 
actin-binding membrane protein.   In Chapter II, I will show that SV reorganizes the actin 
cytoskeleton into dynamic, punctate structures that have characteristics of podosomes and 
invadopodia.  Endogenous SV localizes to both Src-induced podosomes and invadopodia.  
Moreover, SV is important for the function of invadopodia in MDA-MB-231 cells, in 
which overexpression increases, and RNAi-mediated knockdown decreases, matrix 
degradation.  SV, in conjunction with the related protein, gelsolin, contributes to 
MatrigelTM invasion. Chapter III investigates a SV-cytoskeleton-membrane raft complex, 
DRM-H, in COS-7 cells.  Based on the finding that both ERα and ERβ fractionate with 
SV in DRM-H, a role for DRM-H is proposed in nongenomic estrogen signaling.  
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Chapter II 
 
 
 
 
 
Supervillin Reorganizes the Actin Cytoskeleton and Increases Invadopodial 
Efficiency 
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Abstract 
 Tumor cells use actin-rich protrusions called invadopodia to degrade extracellular 
matrix (ECM) and invade tissues; related structures, termed podosomes, are sites of 
dynamic ECM interaction.  We show here that supervillin (SV), a peripheral membrane 
protein that binds F-actin and myosin II, reorganizes the actin cytoskeleton and 
potentiates invadopodial function.  Overexpressed SV induces redistribution of 
lamellipodial cortactin and lamellipodin/RAPH1/PREL1 away from the cell periphery to 
internal sites and concomitantly increases the numbers of F-actin punctae. Most punctae 
are highly dynamic and co-localize with the podosome/invadopodial proteins, cortactin, 
Tks5, and cdc42.  Cortactin binds SV sequences in vitro and contributes to the formation 
of EGFP-SV induced punctae.  SV localizes to the cores of Src-generated podosomes in 
COS-7 cells and with invadopodia in MDA-MB-231 cells.  EGFP-SV overexpression 
increases average numbers of ECM holes per cell; RNAi-mediated knockdown of SV 
decreases these numbers.  While SV knockdown alone has no effect, simultaneous down-
regulation of SV and the closely related protein, gelsolin, reduces invasion through ECM.  
Taken together, our results show that SV is a component of podosomes and invadopodia 
and that SV plays a role in invadopodial function, perhaps as a mediator of cortactin 
localization, activation state, and/or dynamics of MMPs at the ventral cell surface. 
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Introduction 
 During metastasis, tumor cells invade the surrounding extracellular matrix 
(ECM), migrate into the bloodstream, and traverse endothelial barriers at secondary sites 
in distant organs (Condeelis et al., 2005).  ECM degradation, in vitro, involves 
specialized membrane-associated F-actin structures known as podosomes and 
invadopodia (Weaver, 2006; Linder, 2007; Gimona et al., 2008; Machesky et al., 2008).  
Podosomes are endogenously found in cell types that cross tissue boundaries or are 
involved in tissue remodeling, e.g. leukocytes and osteoclasts, respectively (Gimona et 
al., 2008).  Although podosomes contain many focal adhesion proteins and may mediate 
dynamic cell-ECM attachments, they are distinguishable from focal adhesions, which are 
ECM- and integrin-associated complexes that promote cell migration in fibroblasts 
(Zaidel-Bar et al., 2004; Evans and Matsudaira, 2006; Lo, 2006; Romer et al., 2006; 
Spinardi and Marchisio, 2006; Block et al., 2008; Broussard et al., 2008).  Podosomes 
also turn over much faster than do focal adhesions and contain cores of actin filaments 
that are surrounded by rings of vinculin and other focal adhesion proteins (Gavazzi et al., 
1989; Ochoa et al., 2000; Destaing et al., 2003; Evans and Matsudaira, 2006).  Electron 
micrographs of podosomes in Rous sarcoma virus-transformed fibroblasts show that the 
dense microfilamentous material in the core surrounds a central invaginating membrane 
tubule (Nitsch et al., 1989; Ochoa et al., 2000).  Invadopodia mediate ECM degradation, 
are larger and longer-lived than podosomes, and are characterized by surface protrusions 
and large membrane invaginations (Chen and Wang, 1999; Baldassarre et al., 2003; 
Yamaguchi and Condeelis, 2007; Stylli et al., 2008).   
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 Recent studies indicate many functional and compositional similarities between 
podosomes and invadopodia.  Both these structures have been associated with secretion 
of matrix metalloproteinases (MMPs) and endocytosis of degraded matrix components 
(Ochoa et al., 2000; Baldassarre et al., 2003; Clark and Weaver, 2008).  Also, both 
structures contain several proteins in common—including cortactin, Tks5/FISH, and 
Cdc42—in addition to many proteins also found at focal adhesions (Seals et al., 2005; 
Linder, 2007; Yamaguchi and Condeelis, 2007; Block et al., 2008).  Current 
nomenclature is to use the term “invadopodia” for invasive structures in tumor cells and 
to use “podosome” for the invasive/adhesive structures in transformed fibroblasts and in 
cells—such as leukocytes, osteoclasts, endothelial and smooth muscle cells—with 
endogenous or inducible podosomes (Gimona et al., 2008).  However, vascular smooth 
muscle cells invade ECM, and tumor cells contain podosome-like, dynamic “pre-
invadopodial complexes” with short lifetimes that mature into longer-lived invadopodia 
(Yamaguchi et al., 2005a; Furmaniak-Kazmierczak et al., 2007).  In addition, 
invadopodium formation involves sequential stages of cortactin recruitment to 
membranes, MT1-MMP accumulation, matrix degradation, and cortactin dissociation 
(Artym et al., 2006).  Thus, the distinction between “podosomes” and “invadopodia” may 
be as much temporal as compositional, i.e. invasion structures may arise from more 
dynamic podosome-like precursors in both normal tissues and tumors (Linder and 
Aepfelbacher, 2003; Gimona et al., 2008).  Here, we use the current nomenclature for 
podosomes and invadopodia and refer to undefined structures as “actin punctae”. 
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 Supervillin (SV) is one of the largest members of the villin/gelsolin family of 
actin-organizing proteins, which have both overlapping and distinct functions (Silacci et 
al., 2004; Archer et al., 2005; Khurana and George, 2008).  Villin is associated with pre-
cancerous morphological changes in epithelia, and gelsolin is required for the formation 
and degradative activity of osteoclast podosomes; gelsolin also promotes cancer cell 
invasion and motility (MacLennan et al., 1999; Chellaiah et al., 2000; De Corte et al., 
2002; Rieder et al., 2005; Van den Abbeele et al., 2007).  Nonmuscle SV co-purifies 
from neutrophil plasma membranes as a component of a lipid raft-like complex that also 
includes heterotrimeric G proteins, Src family kinases and membrane type 6 MMP (MT6-
MMP) (Nebl et al., 2002), all of which are involved in tumorigenesis and matrix 
degradation (Mareel and Leroy, 2003; Ingley, 2008; Sohail et al., 2008).  A smooth 
muscle isoform of SV, called SmAV, localizes to phorbol ester-induced podosomes in 
A7r5 cells with F-actin, nonmuscle myosin IIB, and extracellular-signal-regulated 
kinases (ERK1/2) (Gangopadhyay et al., 2004).  SmAV is required for normal ERK1/2 
activation downstream of phenylephrine signaling in ferret aorta (Gangopadhyay et al., 
2004), but the functionality of SV isoforms in the formation of podosome-like structures 
has not been explored. 
 Based on its biochemical characteristics, SV is well positioned for a role in 
mediating alterations in the actin cytoskeleton at membranes.  SV co-fractionates with 
membranes and binds very tightly to the membrane bilayer, resisting extraction with 
buffered solutions at pH <12 (Pestonjamasp et al., 1997; Nebl et al., 2002; Oh et al., 
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2003).  One site of membrane attachment is associated with SV amino acids 342-571 
(SV342-571), which interact with the LIM domains of the focal adhesion proteins, 
thyroid receptor-interacting protein 6/zyxin-related protein 1 (TRIP6/ZRP1) and lipoma-
preferred partner (LPP) (Takizawa et al., 2006).  SV also binds avidly to F-actin at three 
sites through which it can either bundle or crosslink actin filaments; to nonmuscle 
myosins IIA and IIB; to the long isoform of myosin light chain kinase (L-MLCK); and to 
calponin (Chen et al., 2003; Takizawa et al., 2007), a negative regulator of podosome 
formation in smooth muscle cells (Gimona et al., 2003).  
 SV potentiates a process that negatively regulates focal adhesion function.  
Overexpressed SV decreases cell adhesion to fibronectin, whereas RNAi-mediated SV 
down-regulation increases cell attachment (Takizawa et al., 2006).  Sequences within the 
SV N-terminus (SV1-171) disrupt stress fibers by inducing apparent hypercontractility of 
myosin II (Takizawa et al., 2006; Takizawa et al., 2007).  Another SV sequence (SV342-
571) counteracts stress fiber and large focal adhesion formation or stability through the 
interaction with TRIP6 (Takizawa et al., 2006).  However, phalloidin staining of 
cytoplasmic F-actin is observed even after disruption of stress fibers in cells expressing 
elevated levels of SV or SV342-571 (Wulfkuhle et al., 1999; Takizawa et al., 2006).  The 
nature of these phalloidin-stained structures has never been explored. 
 The mechanism by which SV and TRIP6 regulate adhesion also is imperfectly 
understood.  Most investigations have focused on the roles of these proteins in “inside-
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out” signaling through other proteins on the cytoplasmic sides of focal adhesions (Yi et 
al., 2002; Lai et al., 2005; Bai et al., 2007; Lai et al., 2007; Takizawa et al., 2007).  An 
alternative, non-mutually exclusive hypothesis, tested in this study, is that SV induces the 
loss of focal adhesion function by promoting the formation of podosomes, invadopodia, 
and ECM degradation. 
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Materials and Methods 
Antibodies, reagents, and constructs 
 Mouse monoclonal anti-vinculin (hVIN1) and anti-gelsolin (Clone GS-2C4) 
antibodies were from Sigma (St. Louis MO), as was affinity-isolated rabbit anti-HA tag.  
Mouse monoclonal anti-cortactin (4F11) and anti-actin (clone C4) antibodies were from 
Millipore Corporation (Bedford, MA).  Mouse monoclonal anti-phosphotyrosine (pTyr-
100) and anti-myc (71D10) antibodies were from Cell Signaling Technology (Danvers, 
MA).  Mouse monoclonal anti-phosphoFAK (pY397) antibody was from BD 
Transduction Laboratories (Franklin Lakes, NJ).  AlexaFluor 488- and 568-conjugated 
secondary antibodies against rabbit and mouse IgGs, and fluorescein- and Texas red-
conjugated phalloidin were from Invitrogen (Carlsbad, CA) and used at 1:2000 dilution.  
Affinity-purified rabbit polyclonal antibodies against SV (H340) and lamellipodin (3917) 
have been described (Nebl et al., 2002; Oh et al., 2003).  
 EGFP-C1 and EGFP-SV vectors were described previously (Wulfkuhle et al., 
1999).  An untagged version of bovine SV was made by cloning the full-length SV 
cDNA into the KpnI and XbaI sites of pTracer-CMV (Invitrogen) (Wulfkuhle et al., 
1999).  His-tagged cortactin(ΔSH3, aa 1-506) was generated from pdsRed-cortactin 
(gifted by Dr. Alan S. Mak, Queen's University, Kingston, Canada) (Webb et al., 2006a) 
after digestion with BglII and cloning into pET30a vector (Invitrogen).  Y527F-Src was 
from the Harold Varmus laboratory (NIH, Bethesda, Maryland).  Myc-tagged Tks5 (myc-
Tks5) (Lock et al., 1998) and HA-tagged Cdc42 (Shinjo et al., 1990) (HA-Cdc42), both 
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in the pEF-BOS expression vector (Mizushima and Nagata, 1990), were kind gifts from 
Drs. Sara Courtneidge (Scripps Research Institute, La Jolla, CA) and Dr. Kozo Kaibuchi 
(Nagoya University, Nagoya, Japan), respectively.  EGFP-MT1-MMP was from Dr. 
Maria C. Montoya (Spanish Nacional Cancer Research Center (CNIO), Madrid, Spain) 
(Galvez et al., 2002; Bravo-Cordero et al., 2007).  
Immunoblotting 
Whole cell lysates were prepared in 1% SDS, PBS, 1 mM PMSF,  and a protease 
inhibitor cocktail containing: 1 mg/ml aprotinin, 1 mM antipain, 2 mM ALLM (calpain 
inhibitor II), 1 mM benzamidine, 10 mME64, 1 mM leupeptin, and 1 mM pepstatin A.  
For each sample, 40 or 50 mg of protein, as determined by BCA Protein Assay (Pierce, 
Rockford, Il), were run on SDS-polyacrylamide gels (Laemmli, 1970), transferred to 
nitrocellulose membranes (Towbin et al., 1979), and probed with primary antibodies 
against supervillin (0.2 – 0.4 µg/ml) and gelsolin (1:5000); β-actin (1:5000 antibody 
dilution) was used as a loading control.  HRP-conjugated goat anti-mouse or goat anti-
rabbit secondary antibodies (Jackson Laboratories, West Grove, PA), diluted 1:20,000, 
were detected by Pierce SuperSignal WestPico chemiluminescence.  Band densities were 
determined using ImageJ (Rasband, W.S., U. S. National Institutes of Health, Bethesda, 
Maryland, http://rsb.info.nih.gov/ij/).  EGFP-SV expression levels were determined by 
comparing band intensities with endogenous SV and correcting for transfection 
efficiency.   
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Cell culture and transfection   
 COS7-2 cells, a highly transfectable clone of COS-7 (Kowalczyk et al., 1997), 
were a generous gift from Dr. Kathleen J. Green (Northwestern University, IL).  COS-7 
cells were grown in Dulbecco’s modified Eagle high glucose media (DMEM, Invitrogen, 
GIBCO #11995) supplemented with 10% fetal calf serum (FCS) for 20 passages.  MDA-
MB-231 breast carcinoma cells were obtained from ATCC (American Type Culture 
Collection, Rockville, MD) and from the Tissue Culture Shared Resource of the 
Lombardi Cancer Center, courtesy of Dr. Susette Mueller (Georgetown University, DC).  
G418-resistant MDA-MB-231 cells that stably overexpress wild-type c-Src (MDA-MB-
231/WT Src cells) were a kind gift from Dr. Toshiyuki Yoneda (U. Texas Health Science 
Center, San Antonio) and Dr. Mueller (Myoui et al., 2003; Bowden et al., 2006).  MDA-
MB-231 cells without (ATCC) and with WT c-Src overexpression were grown in DMEM 
supplemented with 10% FCS and 2 mM L-glutamine (Invitrogen, GIBCO 25030).  
Cultured cells for immunoblots were generously supplied by Drs. Greenfield Sluder 
(primary human foreskin fibroblasts and hTERT-RPE1, Clontech), Lucia Languino 
(LNCaP), K.C. Balaji (LNCaP, C4-2, DU-145), and Arthur Mercurio (MCF10A series).   
 Transfection methods have been described (Takizawa et al., 2006).  Briefly, for 
plasmids, COS-7 cells were transfected using Effectene Transfection Reagent (Qiagen 
Inc.) for 24 hours with the Y527F-Src, HA-Cdc42, and myc-Tks5 plasmids or for 24 or 
48 hours with the EGFP-SV plasmid.  For siRNAs, COS-7 cells were transfected with 
Lipofectamine 2000 (Invitrogen).  MDA-MB-231/WT Src cells were transfected using 
the Nucleofector system (Amaxa, Inc. Gaithersburg, MD), according to manufacturer’s 
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instructions.  Briefly, for each Nucleofection, 1 x 106 adherent cells were trypsinized, 
rinsed with Dulbecco’s PBS, modified (D-PBS, Invitrogen, GIBCO #14190), 
resuspended with 100 µl solution V and with either 40 nM Stealth siRNA or 2 µg 
plasmid, and treated using program X13.  Cells treated with siRNA were incubated for 4 
days prior to experiments, whereas cells treated with plasmid were incubated for 2 days. 
 The dsRNAs targeting COS-7 cell SV have been described (Takizawa et al., 
2007).  Two dsRNAs targeting human SV were made as Stealth duplexes (Invitrogen): 
human (h)SV1, 5’-CAGCCAUAAGGAAUCUAAAUAUGCU-3’ (coding nucleotides 
1680-1704) and hSV2, 5’-GCGAUGUUUGCUGCUGGAGAGAUCA-3’ (coding 
nucleotides 2026-2050).  The Stealth duplex sequence, 5’-
GAACUAUGAAGGACCACCAGAGAUA-3’, was used as a control dsRNA.  A dsRNA 
targeting human gelsolin was also made as a Stealth Duplex with the sequence 5’-
CAGTTCTATGGAGGCGACAGCTACA-3’ (coding nucleotides 1460-1484). Two 
dsRNAs targeting primate cortactins were made as Stealth duplexes:  CT1 5’ 
UCUUGUUCCACACCAAAUUUCCCUC 3’ and CT2 5’ 
GAGGGAAAUUUGGUGUGGAACAAGA 3’.    
Recombinant protein purification and in vitro pulldown assay  
GST-SV fusion fragment proteins were expressed after IPTG induction in 
BL21(DE3)pLysS cells and purified with glutathione-SepharoseTM as previously 
described (Chen et al., 2003).  His-cortactin(ΔSH3) was expressed after induction by 
IPTG and purified by using Ni-NTA Agarose (Qiagen Inc., Valencia, CA).  Eluted 
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proteins were dialyzed in dialysis buffer (50mM Tris pH 8.0, 150 mM NaCl, 1mM DTT, 
10% glycerol).  Dialyzed proteins were frozen quickly in liquid nitrogen and stored at -
80ºC. 
Purified GST-SV fragments were mixed with His-cortactin(ΔSH3) in binding 
buffer (50 mM Tris pH 8.0, 300 mM NaCl, 1% Triton X-100, 1 mM DTT, 10% glycerol, 
1 mM PMSF and protease inhibitor cocktail) and incubated with glutathione-SepharoseTM 
beads for 1 hour at 4ºC with shaking.  The mixtures were then washed five times with 
binding buffer followed by centrifugation at 3000 rpm for 2 min.  Beads were 
resuspended in 2X SDS sample buffer and heated to 95ºC for 5 minutes.  Proteins were 
separated by SDS-PAGE, and transferred to a nitrocellulose membrane. His-
cortactin(ΔSH3) was identified by immunoblotting with monoclonal anti-His antibody 
(clone 27E8, Cell Signaling Technology). 
Live cell imaging 
 COS-7 cells transfected with EGFP-SV were cultured on 22 mm square 
coverslips and sealed into chambers with DMEM, 10% FCS, 10 mM HEPES, without 
phenol red.  After temperature equilibration in a Plexiglass environmental chamber 
heated to 37°C, images focused on the ventral cell surface were acquired for EGFP, using 
an HCX PL Apo, 63X, 1.32 NA, oil immersion objective lens on a DMIRE 2 inverted 
microscope (Leica Microsystems, Allendale, NJ), a Retiga Exi cooled CCD camera 
(QImaging Corp., Burnsby BC, Canada), and OpenLab 3.5.2 software (Improvision, 
Waltham, MA).  Images were processed with OpenLab to enhance contrast and to 
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generate movie files.  Labels and movie titles were added with Adobe Photoshop (Adobe 
Systems Inc., San Jose, CA) and QuickTime Pro (Apple, Cupertino, CA).   
Immunofluorescence 
 Cells were fixed for 10 minutes with 4% paraformaldehyde in PBS, and 
permeabilized for 5 minutes with 0.2% Triton X-100 in PBS before blocking for 30 
minutes with 1% BSA, 0.5% Tween-20 in PBS and immunostaining.  Depending on the 
experiment, cells were stained for cortactin (1:200 dilution), phosphotyrosine (pTyr, 
1:100), myc (1:200), HA (1:100), vinculin (1:200), phosphorylated FAK 397 (pFAK; 
1:100), α-actinin (1:200) and/or anti-SV (1:200).   F-actin was visualized with phalloidin 
conjugated to Texas Red or fluorescein (Invitrogen).  Slides were analyzed with a 40X or 
100X Plan-NeoFluor oil immersion objective (NA 1.3) on a Zeiss Axioskop fluorescence 
microscope, a RETIGA 1300 CCD camera (QImaging), and OpenLab 3.5.2 software.  
Images were adjusted for contrast and brightness, and merged images were assembled 
using Adobe Photoshop software.  For Z-series, images were acquired with a 100X HCX 
PLAN APO objective lens (NA 1.35) using step sizes of 0.2 µm on a DM IRE 2 inverted 
Leica microscope (Leica Microsystems, Bannockburn, IL) with a Retiga Exi cooled CCD 
camera (QImaging) and OpenLab software.  Images were deconvolved using Volocity 
software (Improvision).  Z-series also were obtained with a 100X Plan Apo objective lens 
(NA 1.4) using a Solamere CSU10 spinning disk confocal microscope (Solamere 
Technical Group, Salt Lake City, UT) on a Nikon Eclipse TE-2000 microscope (Nikon 
Instruments Inc., Melville, NY) and a Roper Scientific Cool-Snap HQ2 camera 
(Photometrics, Tucson, AZ). 
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Gelatin-coated coverslips 
 The preparation of fluorescently labeled gelatin coated coverslips was carried out 
as described (Bowden et al., 2001).  Briefly, 2.5% gelatin, 225 bloom (Sigma, type B) 
was conjugated with tetramethylrhodamine-5(and-6)-isothiocyanate (TRITC, Invitrogen 
T-490), dialyzed extensively to remove unbound dye, and stored in PBS with 2% sucrose.  
TRITC-gelatin (200 µL) was heated to 45˚C and spread on ethanol-cleaned coverslips 
(22 mm square).  Excess gelatin was removed, and coverslips were inverted onto chilled 
0.5% glutaraldehyde in PBS for 15 minutes.  Coverslips were then washed with PBS, and 
unreacted aldehyde groups were quenched with 5 mg/ml sodium borohydride for 5-10 
minutes.  After washing with PBS, coverslips were then sterilized briefly with 70% 
ethanol and incubated at 37˚C in serum-free DMEM for one hour prior to plating cells.  
Cells in complete DMEM then were incubated for 6 hours on the gelatin and fixed with 
4% paraformaldehyde, as described above. 
Matrigel invasion assays 
 Cell invasion assays were performed using BioCoat™ Matrigel™ Invasion 
Chambers (BD Biosciences, Franklin Lakes, NJ, No. 354480), according to the 
manufacturer’s instructions.  Briefly, ~5 x 104 siRNA-treated MDA-MB-231/WT Src 
cells in serum-free DMEM were added to the upper wells of invasion chambers that 
contained DMEM with 10% serum in the bottom wells.  Cells were allowed to migrate 
for 20 hours, when cells remaining on the upper side of the filter were removed with 
moistened cotton swabs. Migrated cells were fixed and stained with the HEMA 3® Stain 
Set (Fisher Scientific, Kalamazoo, MI).  Five representative images were taken from each 
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insert with 10X magnification.  Cells from the Matrigel inserts were counted using the 
Cell Counter plugin for ImageJ.  Cells from control inserts were counted using the 
Analyze Particles command in ImageJ after using the Threshold and Watershed 
commands to identify individual cells.  Invasion indices were determined as ratios of 
cells migrating in the presence vs. absence of Matrigel™ to control for changes in cell 
motility and by normalizing experimental invasion indices against the mean value 
obtained for cells treated with control siRNA.   
FACS analyses 
 The total amounts of cortactin in COS-7 cells expressing EGFP or EGFP-SV were 
assayed after lifting 1 x 106 cells from plates with 0.1% trypsin, 0.4 mg/ml EDTA.  The 
cells were washed twice with PBS and fixed with 2% paraformaldehyde in PBS for 20 
min at room temperature with rotation in a 1.5-ml tube.  Fixed cells were washed once 
and made permeable with 0.1% Triton X-100 in PBS for 5 min at room temperature with 
rotation.  After blocking for 30 minutes with sterile-filtered 4% FBS, 0.05% sodium 
azide, PBS, the cells were incubated for another 30 minutes on ice in blocking buffer 
containing either 0.67 µg/ml mouse anti-cortactin antibody or control mouse IgG1 
(Leinco Technologies, St. Louis, MO).  Cells were washed three times with blocking 
buffer and then incubated for 15 min on ice with secondary antibody, AlexaFluor647-
conjugated goat anti-mouse IgG F(ab2) (Invitrogen, 1:5000).  The cells were washed 
three times with blocking buffer and resuspended into 0.5 ml of PBS containing 0.5% 
BSA in Falcon tubes for FACS analysis. 
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Statistical Analyses 
 Statistical significance was assessed using InStat 3 for Macintosh (GraphPad 
Software, Inc., La Jolla, CA).  Unless otherwise stated, two-tailed p values were 
determined by one-way ANOVA with a Tukey-Kramer or Student-Newman-Keuls 
multiple comparisons post test.  As noted in figure legends, some pairs of groups also 
were compared using unpaired t tests. 
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Results 
SV Promotes Restructuring of the Actin Cytoskeleton. 
 SV overexpression increases F-actin punctae.  Increased levels of SV decrease 
the numbers of COS-7 cells containing stress fibers (Takizawa et al., 2006).  As 
compared with overexpressed EGFP alone (Figure 2-1A, panels a-c), overexpression of 
either EGFP-tagged SV (EGFP-SV) (Figure 2-1A, panels d-f) or untagged SV (Figure 
2-1A, panels g-i) increases the numbers of F-actin punctae (Figure 2-1A, panels e, h vs. 
b, insets).  These punctae, which are ~0.5 µm in diameter, can be either round or 
irregularly shaped.  They are prominent at the ventral surfaces of cells expressing EGFP-
SV but are also found near nuclei, especially in EGFP-expressing control cells (Figure 2-
2).  In wide-field fluorescence (Figure 2-1A), the mean numbers of ventral F-actin 
punctae in cells expressing EGFP-SV (Figure 2-1B) or untagged SV (Figure 2-1C) 
increase ~7-fold, as compared with mock-transfected cells or cells expressing only 
EGFP, indicating specificity for SV sequences.  The increase in ventral F-actin punctae in 
EGFP-SV transfected cells was not due solely to protein expression levels because even 
with very high expression of EGFP, the number of these punctae does not increase to 
levels seen with EGFP-SV (Figure 2-1D).  This increase in ventral F-actin punctae is 
apparently a gain of function because RNAi-mediated reduction of endogenous SV to 
~20 ± 5% of normal levels does not significantly reduce the low background numbers of 
F-actin punctae in COS-7 cells (not shown). 
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Figure 2-1.  Overexpression of EGFP-SV in COS-7 cells increases the numbers of 
cytoplasmic F-actin punctae.   
(A) COS-7 cells were transfected for 48 hours with vectors encoding EGFP (a-c), EGFP-
SV (d-f), or GFP plus untagged supervillin (g-i).  Cells were fixed and stained for F-actin 
using Texas Red phalloidin (b, e, h).  Bar, 20 µm.  Insets enlarged 4 fold.  Overlap in 
white.   
(B, C) F-actin punctae were counted in untransfected cells after a mock treatment with 
transfection agent alone, or in cells expressing EGFP, EGFP-SV, or GFP as a marker for 
untagged SV.  Distributions of individual counts and their means are shown.  Both 
EGFP-SV and untagged SV differed from controls, p ≤ 0.001, n = 25 – 28/group.   
(D) The relative amounts of EGFP (closed symbols) or EGFP-SV (open symbols) in 
individual cells were estimated from total luminosities of wide-field microscopic images.  
The plot shows the number of F-actin punctae per cell vs. luminosity. EGFP-SV 
expression levels were 12.5 ± 0.7 (mean ± s.d., n=3) times that of endogenous SV.  At 
these expression levels, no significant trend was detected for either data set.  
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Figure 2-2.  Confocal images of F-actin punctae at (A) basal surfaces and (B) 2 µm 
higher sections of COS-7 cells expressing EGFP-SV or EGFP alone.  Bar, 10 µm. 
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 Most EGFP-SV punctae are dynamic, but these structures are probably 
heterogeneous in nature.  In live cell imaging, ~94% of the EGFP-SV punctae in the 
cell periphery were highly dynamic and short-lived (Figure 2-3; Video 1, available at 
http://www.molbiolcell.org/content/vol0/issue2008/images/data/E08-08-
0867/DC1/Smov1.mov).  Although occasional movements of ~1.0 µm/sec were seen, the 
instantaneous velocities of these punctae averaged 0.36 ± 0.05 µm/sec (mean ± s.e.m., n 
= 19) over their lifetimes of 2.9 ± 0.3 min (mean ± s.e.m., n = 93) (Figure 2-3A, 2-2B).  
These dynamic short-lived punctae moved both towards and away from the cell periphery 
(Figure 2-3A, arrowheads; Video 1).  The ~6% of the EGFP-SV punctae that were 
longer lived exhibited lifetimes of at least 30.5 ± 1.6 min (mean ± s.e.m., n = 6) (Figure 
2-3B) and were largely restricted in localization (Figure 2-3C), with signal intensities 
that could vary over time (Figure 2-3A, double arrows).  Other longer-lived punctae 
tumbled in place, as though they might be associated with larger, vesicular structures and 
exhibited sporadic, rapid movements (Figure 2-3A, arrow; Figure 2-3C).  The mean 
instantaneous velocity of EGFP-SV punctae is most consistent with directional 
movements propelled by kinesins (~0.5 µm/sec), but the variable directionalities and the 
range of observed velocities suggest the possibility of multiple propulsion mechanisms, 
including actin comet tails (~0.17 µm/sec), myosin Vb (0.22 µm/sec), and dynein (~0.9 
µm/sec) (Porter et al., 1987; Woehlke et al., 1997; Benesch et al., 2002; Toba and 
Toyoshima, 2004; Paluch et al., 2006; Watanabe et al., 2006). 
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Figure 2-3.  Most EGFP-SV punctae are dynamic and short lived; a few are longer lived 
and relatively stable.   
(A) Time lapse sequence of EGFP-SV punctae in COS-7 cells on glass coverslips.  
Images were taken every 12 seconds for 60 min.  Bar, 10 µm.  Examples of short-lived 
(arrowheads) and long-lived (arrows) punctae are indicated.  
(B) Distribution of individual punctae lifetimes; n = 99.   
(C) Sample trajectories of EGFP-SV punctae with associated lifetimes.   
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EGFP-SV punctae contain podosome markers, but not focal adhesion proteins.  The 
lifetimes and dynamic behavior of most EGFP-SV punctae are reminiscent of podosomes 
or invadopodial precursors (Yamaguchi et al., 2005a; Evans and Matsudaira, 2006).  
While the localization of some punctae above the ventral cell surface (Figure 2-2) argues 
against a 1:1 identity with podosomes, most ventral EGFP-SV punctae do co-localize 
with podosome/invadopodial proteins (Figure 2-4).  For instance, ~91% of the EGFP-SV 
punctae co-localize with endogenous cortactin (Figure 2-4A-C, boxes), a protein 
required for the formation and function of invadopodia (Bowden et al., 1999; Artym et 
al., 2006; Clark et al., 2007; Ayala et al., 2008; Clark and Weaver, 2008).  Also, ~75% 
and ~50%, respectively, of the EGFP-SV punctae associate with co-expressed myc-
Tks5/FISH (Figure 2-4D-F) and HA-Cdc42 (Figure 2-4G-I), other proteins important 
for invadopodial function (Nakahara et al., 2003; Courtneidge et al., 2005; Yamaguchi et 
al., 2005a).  About 27% of the EGFP-SV punctae contain endogenous phosphotyrosine 
(Figure 2-4J-L), a marker for invadopodia, tyrosine kinase-associated intracellular 
vesicles, and focal adhesions (Zamir et al., 1999; Bowden et al., 2006; Sandilands and 
Frame, 2008).  By contrast, only ~3% or ~5%, respectively, of the EGFP-SV punctae co-
localize with vinculin or phosphorylated focal adhesion kinase (pFAK) (Figure 2-4M-
R), focal adhesion proteins that are present as rings in podosomes but absent from most 
invadopodia (Bowden et al., 2006; Machesky et al., 2008).  Most of the overlap between 
EGFP-SV and vinculin and pFAK is at focal adhesions, as previously reported (Figure 2-
4M-R, arrows) (Wulfkuhle et al., 1999; Takizawa et al., 2006). 
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Figure 2-4.  EGFP-SV punctae co-localize with cortactin and exogenous Tks5 and 
Cdc42, but not with phosphoFAK or vinculin.   
COS-7 cells expressing EGFP-SV (A, D, G, J, M, P) were stained with antibodies 
against endogenous cortactin (B), phosphotyrosine (pTyr, K), vinculin (N), or 
phosphorylated FAK (pFAK, Q) or with antibodies against tags on exogenously 
expressed Tks5 (E) or Cdc42 (H).  EGFP-SV is green in the merged images (C, F, I, L, 
O, R); other proteins are shown in magenta; overlap appears white.  Insets, 4-fold 
enlargements of areas within boxes.  Arrows denote focal adhesions.  Bar, 10 µm.   
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 SV causes a redistribution of cortactin.  Because EGFP-SV reorganizes F-actin 
and overlaps extensively at punctae with cortactin, a protein that organizes actin at 
lamellipodial ruffles and is required for podosomes and invadopodia (Buday and 
Downward, 2007; Ammer and Weed, 2008; Weaver, 2008), we investigated cortactin 
localization in cells expressing EGFP-SV (Figure 2-5).  In mock-transfected cells and in 
cells expressing EGFP alone for 48 hours, ~70% (50-109 cells per experiment, n = 3) of 
the cells exhibit areas of contiguous, ≥20-µm-long cortactin staining at their peripheries 
(Figure 2-5A, arrowheads; Figure 2-5B), as originally described (Wu and Parsons, 
1993).  By contrast, only 33.1% ± 5.7 % (~50 cells per experiment, n = 6, p < 0.0001) of 
cells overexpressing EGFP-SV contained strong contiguous peripheral cortactin staining 
by 48 hours post-transfection (Figure 2-5A, d-f, arrows; Figure 2-5B); slight decreases 
were observed after only 24 hours (not shown).  Cortactin was apparently redistributed to 
the cell interior, as opposed to being differentially stabilized or cleaved by calpain (Perrin 
et al., 2006), because FACS analyses showed no changes in total amounts of cellular 
cortactin with increasing expression of either EGFP or EGFP-SV (Figure 2-5C). 
 
 Other lamellipodial markers also are displaced.  To determine whether EGFP-
SV promotes the selective redistribution of cortactin, we also monitored two other 
proteins characteristically concentrated at lamellipodia, lamellipodin/RAPH1/PREL1 
(Figure 2-6A-C) (Krause et al., 2004) and filamin A/ABP280 (Figure 2-6D-F) (Stendahl 
et al., 1980).  EGFP-SV induces a significant loss of lamellipodin from the  
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Figure 2-5.  Expression of EGFP-SV leads to redistribution of cortactin.   
(A) COS-7 cells expressing EGFP alone (a; green in c) or EGFP-SV (d; green in f) for 
48 hours were immunostained for endogenous cortactin (b, e; red in c, f). Cells were 
scored as containing (arrowheads) or lacking (arrows) peripheral cortactin.  Bar, 50 µm.   
(B) Percentages of cells with continuous peripheral cortactin staining 48 hours after mock 
transfection (Mock) or expression of EGFP alone (EGFP) or EGFP-SV (EGFP-SV).  
Means ± s.d.; ***, p < 0.0001.  
(C) Two-color FACS analyses showing no change in the levels of total cellular cortactin 
caused by expression of EGFP or EGFP-SV in COS-7 cells. 
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Figure 2-6.  EGFP-SV redistributes lamellipodin/RAPH1/PREL1, but not filamin A, 
within 24 hours.    
(A, D) COS-7 cells expressing EGFP alone (a) or EGFP-SV (c) for 24 hours were 
immunostained for endogenous lamellipodin (b, d in A) or filamin A (b, d in D).  Cells 
were scored as containing (arrowheads) or lacking (arrows) peripherally localized 
protein.  Bars, 50 µm.   
Percentages of cells with peripheral (B) lamellipodin or (E) filamin staining 24 hours 
after mock transfection (Mock) or expression of EGFP alone (EGFP) or EGFP-SV 
(EGFP-SV).  Means ± s.d.; *, p < 0.05; n = 2 (B); n = 3 (E).   
Overlap (arrows), or lack of overlap (arrowheads), of EGFP-SV punctae with 
endogenous (C) lamellipodin and (F) filamin.  Bars, 20 µm. 
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cell periphery (Figure 2-6A, 2-6B).  By contrast, filamin remains at the cell periphery in 
COS-7 cells expressing EGFP-SV, but the extent and intensity of the peripheral filamin 
signal appears reduced (Figure 2-6D, 2-6E).  Unlike the nearly perfect overlap seen with 
cortactin antibody (Figure 2-4A-C), most EGFP-SV punctae lack lamellipodin and 
filamin (Figure 2-6C, 2-6F, arrowheads), with only ~38% and ~35%, respectively, of 
the EGFP-SV punctae overlapping with signal from antibodies against these two proteins 
(Figure 2-6C, 2-6F, arrows).   
 
 Cortactin binds SV in vitro.  Due to the redistribution of cortactin upon EGFP-
SV overexpression (Figure 2-5) and the striking amount of co-localization of the two 
proteins (Figure 2-4A-C), compared to the relatively weak overlap with lamellipodin and 
filamin (Figure 2-6C, 2-6F), we investigated whether cortactin binds SV directly.  GST 
or GST-tagged SV N-terminal fragments were mixed with His-cortactin(ΔSH3), and 
interacting proteins were co-sedimented with glutathione-SepharoseTM beads (Figure 2-
7A).  Even with significant His-cortactin(ΔSH3) input (Figure 2-7A, a-b, lanes 1), there 
was no detectable binding with GST or beads only (lanes 2, 3).  His-cortactin(ΔSH3) was 
pulled down with SV amino acids SV1-340 (lanes 4), SV570-830 (lanes 7) and SV340-
830 (lanes 8). The lack of binding with SV171-340 (lanes 5) or SV340-570 (lanes 6) 
indicates likely cortactin binding sequences within SV1-171 and SV570-830.   
 
 Cortactin increases the numbers of EGFP-SV F-actin punctae.  To see if 
cortactin is necessary for the formation of EGFP-SV-induced F-actin punctae, we  
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Figure 2-7.  Cortactin binds SV in vitro and contributes to the formation of EGFP-SV 
induced punctae in vivo.  
(A)  His-cortactin(ΔSH3) (Input, lane 1) was mixed with glutathione-SepharoseTM beads 
and the indicated GST fusion proteins (lanes 2, 4-8) or with glutathione-SepharoseTM 
beads alone (lane 3) for 1 hour.  Beads were washed, pelleted and heated in SDS sample 
buffer and interacting proteins were subjected to SDS-PAGE and (a) stained with 
Coomassie blue or (b) transferred to nitrocellulose and immunoblotted for the His tag 
(n=3).  Arrowhead denotes His-cortactin(ΔSH3).  Input lane (a) was digitally moved to 
match immunoblot (b).   
(B) Cortactin protein levels in COS-7 cells 4 days post-transfection with control siRNA 
(CON, lane 1) or cortactin siRNA (CT1, CT2, lanes 2, 3.  β-actin was the loading control.  
Percent of cortactin remaining is shown under cortactin bands (n=1).   
(C) Cortactin knockdown cells were transfected with plasmids encoding EGFP or EGFP-
SV at day 3 of siRNA treatment, and F-actin punctae were visualized with phalloidin 
after an additional 24 hours (n=3). Statistically significant differences were determined 
by unpaired two-tailed Student t-tests and with the Student-Newman-Keuls multiple 
comparison test (*, p<0.05, ***, p<0.001). 
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reduced cortactin levels by 74% of control-treated cells (Figure 2-7B, CON, lane 1) 
using two different cortactin-specific siRNAs (CT1, CT2; lanes 2, 3).  Cortactin 
knockdown cells were transfected with plasmids encoding EGFP or EGFP-SV and scored 
for the number of F-actin punctae (Figure 2-7C).  As in the absence of siRNA treatment 
(Figure 2-1), there is a significant difference between EGFP and EGFP-SV transfected 
cells treated with the control siRNA (***, p<0.001) (Figure 2-7C).  Although cortactin 
knockdown has no significant effect on the numbers of F-actin punctae in EGFP-
transfected cells, the reduction in cortactin levels inhibits ~50% of the increase in 
numbers induced by EGFP-SV (*, p<0.05).  Therefore, the podosome and invadopodial 
protein cortactin contributes to the formation of EGFP-SV punctae. 
 
Role of SV at Podosomes and Invadopodia 
 Endogenous SV localizes to Src-induced podosomes and areas of matrix 
degradation in COS-7 cells.  To further examine the relationship between SV and 
podosomes/invadopodia, we localized endogenous SV in COS-7 cells containing 
podosomes induced by constitutively active c-Src-Y527F (Figure 2-8).  Each Src-
induced podosome consists of a core of F-actin, cortactin, and other proteins surrounded 
by a ring of focal adhesion proteins (Linder and Aepfelbacher, 2003).  Endogenous SV 
co-localizes extensively with F-actin and cortactin at the podosome cores (Figure 2-8A-
B) and less well with α-actinin (Figure 2-8C), which associates with both the podosome 
core and ring (Linder and Aepfelbacher, 2003).  Little overlap of SV with the focal  
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Figure 2-8.  Endogenous supervillin localizes to the cores of Src-induced podosomes.   
COS-7 cells were transfected with Y527F Src, immunostained for SV and stained for (A) 
F-actin with phalloidin or with antibody against endogenous (B) cortactin, (C) α-actinin, 
(D) pFAK or (E) vinculin and visualized after deconvolution of images acquired with 
0.2-µm Z-steps.  F-actin and cortactin localize to podosome cores, α-actinin to cores + 
rings, and vinculin and phosphorylated FAK (pFAK) to podosome rings (Linder and 
Aepfelbacher, 2003).   
Individual podosomes in the XY view (arrowheads) have been enlarged to the same 
scale as the XZ and YZ views. SV, green; other proteins magenta; and overlaps in white.  
Bars, 10 µm in main images, 1 µm in insets. 
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Figure 2-9.  Controls supporting the 
localization of SV at the cores of Src-
induced podosomes.   
(A, B) The accessibility of SV 
epitopes at podosomes is independent 
of filter sets used for co-localization.  
COS-7 cells were transfected with 
Y527F Src, stained for endogenous 
SV in the red channel, and for F-actin 
(A) or vinculin (B) in the green 
channel, and visualized after 
deconvolution of images acquired 
with 0.5-µm Z-steps.   
(C) EGFP-SV in the green channel 
localizes throughout the length of the 
podosome core, whereas the H340 
antibody against the SV N-terminus, 
visualized in the red channel, 
differentially recognizes the apical 
ends of podosome cores.  Images were 
acquired with 0.2-µm Z-steps.   
(A – C) Individual podosomes in the 
XY view have been enlarged to the 
same scale as the XZ and YZ views.  
Bars: 10 µm in main images, 1 µm in 
insets.  Overlaps appear yellow. 
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adhesion proteins, phosphorylated FAK and vinculin, is observed in podosome rings 
(Figure 2-8D-E).  The overall SV staining pattern at podosome cores is generally more 
punctate than those of the other proteins (Figure 2-8, left, x-y inset) although foci of SV 
and cortactin show frequent overlaps (Figure 2-8B).  Immunolocalization of SV shows a 
preferential exposure of the SV epitope at the apical ends of the podosomes, near the 
interface with the cytoplasm (Figure 2-8), regardless of whether SV is imaged with green 
(Figure 2-8) or red (Figure 2-9A, B) fluorophores.  However, co-localization of EGFP-
SV and antibody-stained SV indicates that the N-terminal epitope recognized by the 
antibody is preferentially shielded near the base of the podosome cores (Figure 2-9C).  
Thus, as has been reported for the transmembrane receptor CD44 (Chabadel et al., 2007), 
the peripheral membrane protein SV marks podosome cores.  EGFP-SV also localizes to 
areas of matrix degradation in COS-7 cells on fluorescently labeled gelatin although these 
cells do not efficiently degrade matrix (Figure 2-10).  
 
 Many tumor cell lines contain relatively high levels of SV.  To identify an 
invasive cell line in which we could examine SV function in matrix degradation and 
invasion, we screened a number of tumor cell lines for the presence of endogenous SV.  
Abundant levels of SV message have been reported in HeLa cervical adenocarcinoma, 
SW480 colorectal adenocarcinoma, and A549 lung carcinoma cells (Pope et al., 1998).  
In agreement with previous results (Pestonjamasp et al., 1997), we find that HeLa cells 
contain higher levels of endogenous SV than do untransformed cell lines (Figure 2-11A,  
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Figure 2-10.  EGFP-SV induced punctae localize to areas of degraded matrix in COS-7 
cells. 
COS-7 cells were transfected with either EGFP (A-D) or EGFP-SV (E-H) and plated on 
TRITC-labeled gelatin coated coverslips for 24 hours, fixed and stained with Texas Red-
phalloidin to visualize F-actin. Bar, 20 µm. Area within boxes is enlarged 4-fold and 
shown in inset. 
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Figure 2-11.  SV is abundant in many transformed cells.   
(A) Immunoblot of endogenous SV in primary human foreskin fibroblasts (FsF, lane 1), 
telomerase-immortalized retinal pigmented epithelial (RPE1) cells (lane 2), HeLa 
cervical adenocarcinoma cells (lane 3), MDA-MB-231 breast adenocarcinoma cells (231, 
lane 4), metastatic androgen-dependent LNCaP (lane 5) and androgen-independent C4-2 
(lane 6) prostate adenocarcinomas, and metastatic DU-145 carcinoma cells (lane 7).   
(B) Immunoblot of endogenous SV in HeLa cells (lane 1), spontaneously immortalized 
MCF10A1 breast epithelial cells (10A1, lane 2), H-Ras expressing hyperplastic 
MCF10AT1k.cl2 breast cells (10AT, lane 3), MCF10CA1h low-grade breast carcinoma 
cells (CA1h, lane 4), and MCF10CA1a.cl1 high-grade metastatic breast carcinoma cells 
(CA1a, lane 5).  Antibodies against the transferrin receptor (TfR) or β-actin were used as 
loading controls. 
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lanes 1-3).  A number of human prostate (LNCaP, C4-2, DU-145) (Stone et al., 1978; 
Thalmann et al., 1994) and breast (MCF10A1, MCF10AT1k.cl2, MCL10CA1h, 
MCF10ACA1a.cl1, MDA-MB-231) (Tang et al., 2003) epithelial cell lines contain 
abundant endogenous SV (Figure 2-11).  The highest SV levels were seen in MDA-MB-
231 metastatic breast carcinoma cells, which inherently form invadopodia on ECM 
substrates (Chen et al., 1994). 
 
 Endogenous SV localizes to invadopodia in MDA-MB-231 cells.  In MDA-
MB-231 cells on gelatin, endogenous SV co-localizes with the large ventral 
accumulations of cortactin and F-actin characteristic of invadopodia (Figure 2-12A) 
(Artym et al., 2006).  In addition, mRFP-SV is found in proximity with ~45% of the 
vesicles or invadopodia that contain EGFP-MT1-MMP (Figure 2-12B), the membrane-
bound MMP responsible for most matrix degradation in MDA-MB-231 cells (Artym et 
al., 2006).  Endogenous SV also is concentrated at and within regions of matrix 
degradation, as identified by black areas in thin films of TRITC-labeled gelatin (Figure 
2-12C).  In XZ and YZ views, SV is seen both within and above the holes in the gelatin 
matrix created by invadopodia (Figure 2-12C, a-d). By contrast, little overlap is seen 
between EGFP-SV and the pY-100 phosphotyrosine antibody (Bowden et al., 2006) 
(Figure 2-13).  Taken together, these data support an association between SV and 
invadopodia.  
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Figure 2-12.  Supervillin localizes at 
and within MDA-MB-231 cell 
invadopodia. 
(A) MDA-MB-231 cells were plated 
on unlabeled gelatin-coated 
coverslips for 3 hours, fixed and 
stained with antibodies (SV, 
cortactin) and/or phalloidin (F-
actin), as noted, and imaged by 
wide-field microscopy. Merges show 
supervillin in red, cortactin in green 
and F-actin in blue. Bars, 10 µm (top 
row) and 1 µm (bottom row).  
(B)  MDA-MB-231/WT Src cells 
were transfected with mRFP-SV and 
EGFP-MT1-MMP.  Cells were 
plated on unlabeled gelatin-coated 
coverslips for 6 hours, fixed and 
stained with phalloidin (F-actin) and 
imaged by wide-field microscopy. 
Merges show mRFP-SV in red, 
EGFP-MT1-MMP in green and F-
actin in blue.  Arrows indicate co-
localization; arrowheads denote 
mRFP-SV localization surrounding 
EGFP-MT1-MMP vesicle.  
(C) MDA-MB-231 cells were plated 
on TRITC-labeled gelatin-coated 
coverslips for 6 hours, fixed and 
stained with anti-SV antibodies and 
imaged by confocal microscopy as a 
Z-series with 0.2 µm steps.  Merges 
show supervillin in green and 
TRITC-gelatin in red.  An XY view 
of such a cell is shown (top row).  
Areas inside the boxes were enlarged 
4 fold (second row).  Eight-fold enlargements of XZ and YZ views corresponding to a, b, 
c, d are shown below XY views.  Bars, 10 µm (top row), 5 µm (second row), and 1 µm 
(bottom row). 
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Figure 2-13.  EGFP-SV overlaps only slightly with phosphotyrosine.   
MDA-MB-231/WT Src cells were transfected with EGFP-SV (B, F, green in merge), 
plated on TRITC-labeled gelatin coated coverslips (A, E, red in merge) for 6 hours, fixed 
and stained with anti-phosphotyrosine antibody (pTyr, C, G, blue in merge).  Bar, 20 µm. 
Area within boxes is enlarged 5-fold and shown in bottom row. 
 
 49 
 SV overexpression increases the numbers of matrix degradation sites formed 
per cell.  We tested whether SV affects ECM degradation in highly invasive MDA-MB-
231 cells that stably overexpress WT Src (MDA-MB-231/WT Src) (Myoui et al., 2003; 
Bowden et al., 2006).  Transient overexpression of EGFP-SV to levels that were 4.9 ± 1.5 
(mean ± s.d., n = 3) times greater than endogenous SV levels doubled the average number 
of holes per cell in the fluorescent gelatin matrix (Figure 2-14B vs. Figure 2-14A, 2-
14C; Figure 2-14D).  However, the percentage of cells that made holes did not differ 
significantly from controls (Figure 2-14E).  Similar results are seen with MDA-MB-231 
cells not transfected with c-Src (Figure 2-15). This SV-promoted increase in the numbers 
of holes per cell corresponds to a 4.2-fold increase in the mean area of degraded matrix 
per cell (Figure 2-16).  These results are consistent with a SV-mediated increase in the 
numbers, efficiency, or dynamics of sites of ECM degradation.  
 
 SV underexpression decreases matrix degradation, especially in the cell 
center.  Conversely, reduction of endogenous SV levels reduces the apparent numbers of 
ECM-degrading sites (Figure 2-17).  Each of two siRNAs reduces SV levels in MDA-
MB-231/WT Src cells to about 30% of endogenous levels without adversely affecting the 
expression level of the related protein, gelsolin (Figure 2-17A, lanes 1-2 vs. lane 3).  
While these reduced levels of SV do not affect the percentages of cells associated with 
degraded matrix (Figure 2-17B), the mean numbers of holes per cell (Figure 2-17C) and 
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Figure 2-14.   Overexpression of EGFP-SV increases the number of matrix holes formed 
per cell.   
MDA-MB-231/WT Src cells were transfected with either EGFP alone (A), or EGFP-SV 
(B), or were mock transfected (C).  Cells were plated on TRITC-labeled gelatin coated 
coverslips for 6 hours before visualization by green (a) and red (b) fluorescence and 
phase contrast (d); merged green and red images also are shown (c).  Bar, 20 µm.   
(D) The numbers of holes in the red gelatin matrix (representative of invadopodia) per 
cell were counted.  EGFP-SV cells had a significant (***, p < 0.001, n = 8) increase in 
the number of associated holes per cell.   
(E) The percentage of cells with some matrix degradation was not significantly different 
among the three conditions. 
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Figure 2-15.  Increases in the numbers of matrix holes formed per cell induced by EGFP-
SV do not require co-overexpression of c-Src.   
MDA-MB-231 cells without additional c-Src were transfected with either EGFP alone 
(A), or EGFP-SV (B), or were mock transfected (C).  Cells were plated on TRITC-
labeled gelatin coated coverslips for 12 hours before visualization by green (a) and red 
(b) fluorescence and phase contrast (d); merged green and red images also are shown (c).  
Bar, 20 µm.   
(D) The numbers of holes in the red gelatin matrix per cell were counted.  EGFP-SV cells 
had a significant increase in the number of associated holes per cell (***, p < 0.001, n = 
8).   
(E) The percentage of cells with matrix degradation was not significantly different among 
the three conditions. 
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Figure 2-16.  Overexpression of EGFP-SV in MDA-MB-231/WT c-Src cells increases 
the extent of matrix degradation.   
MDA-MB-231/WT c-Src cells expressing either EGFP or EGFP-SV at comparable levels 
were plated on TRITC-labeled gelatin coated coverslips for 6 hours before visualization 
by green and red fluorescence.  Regions of interest were drawn to include the matrix 
surrounding, as well as underneath, the fluorescent cells.  Fractional areas of degraded 
matrix and cellular fluorescence were determined using ImageJ 1.40g, as described at 
www.nist.gov/lispix/imlab/measure/pctarea.html and plotted as ratios.  Means ± s.d. were 
0.22 ± 0.39 and 0.92 ± 1.03 for cells expressing EGFP vs. EGFP-SV, respectively; 
median percentages of degraded matrix were 0.12 and 0.68, respectively; n = 38, P = 
0.002.  
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the percentages of cells with holes underneath the central region of the cell are decreased, 
as compared with cells treated with a control siRNA (Figure 2-17D; 2-17E, e vs. b).  By 
contrast, matrix degradation in these assays is unaffected by down-regulation of gelsolin 
(Figure 2-17A, lane 4; 2-17B – 2-17D), a SV family member involved in podosome 
assembly in osteoclasts and matrix invasion of MDA-MB-231 cells (Chellaiah et al., 
(Chellaiah et al., 2000; Van den Abbeele et al., 2007).  Double knockdowns of SV and 
gelsolin (Figure 2-17A, lane 5) result in the same number of total holes per cell as 
observed for controls (Figure 2-17C) and are not significantly more effective than 
knockdown of SV alone in decreasing the presence of central holes (Figure 2-17D).  
However, the locations of the holes in the matrix for the SV/gelsolin double knockdown 
tended to be shifted away from the cell centers towards the cell edges, as was also 
observed for knockdown of SV alone (Figure 2-17E, panel h).  Thus, SV apparently 
affects both the numbers and locations of the holes in the fluorescent matrix.  
 
 SV knockdown does not decrease ventral F-actin punctae.  Although SV can 
increase F-actin bundling in vitro and in vivo (Wulfkuhle et al., 1999; Chen et al., 2003), 
SV probably is not required for the formation of ventral F-actin structures (Figure 2-
17E).  MDA-MB-231/WT Src cells with reduced levels of SV and significantly reduced 
sites of matrix degradation (Figure 2-17E, e, h vs. b) still contain apparently normal 
levels of F-actin structures within the ventral focal plane (Figure 2-17E, d, g vs. a).  In 
addition, COS-7 cells expressing constitutively active c-Src-Y527F form similar numbers 
of podosomes, regardless of whether their SV levels are normal or have been reduced to  
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Figure 2-17.  
Underexpression of 
endogenous SV decreases 
the numbers of matrix 
holes per cell, especially 
under the center of the cell.   
MDA-MB-231/WT Src 
cells were transfected with 
either control siRNA (Con) 
or siRNAs targeting SV 
(SV1, SV2), the related 
protein, gelsolin (Gel), or 
both SV and gelsolin 
(SV1/Gel).  These cells 
were analyzed for (A) 
protein levels by 
immunoblotting, (B) the 
percentages of cells 
associated with at least one 
area of degraded matrix 
(hole), relative to control-
treated cells, (C) the mean 
numbers of holes per cell, 
relative to control-treated 
cells, and (D) the 
percentages of cells with 
holes underneath the cell 
center.  The percentages in 
panel A denote the mean 
levels (n = 4) of SV and 
gelsolin, relative to control-
treated cells, after normalization to the β-actin loading control.  (B, C, D) Means ± s.d.; n 
= 6.  Asterisks in panels C and D denote significant differences (***, p < 0.001, **, p < 
0.01; *, p < 0.05) from controls in unpaired t tests.   
(E) Representative micrographs of cells treated with control siRNA (a-c), SV1 siRNA 
(d-f), or both SV1 and gelsolin (SV1/Gel) siRNAs (g-i) and stained for F-actin (a, d, g) 
or sites of matrix degradation (b, e, h).  For merged images (c, f, i), holes in the matrix 
were visualized as red spots by pseudocoloring the images in b, e and h after inverting 
and thresholding their luminosities.  Note the sites of matrix degradation at the cell 
periphery (arrows) and underneath the cell center (arrowheads).  Overlaps appear yellow 
or orange.  Bar, 20 µm. 
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Figure 2-18.  SV knockdown has no effect on Src-induced podosome formation.  
COS-7 cells were transfected for SV knockdown with two siRNAs against SV (SV1, 
SV2), or two control siRNAs (Con1, Con2) for 4 days.  Mock (transfection reagent 
alone) and no treatment served as additional controls.  On day 3 of knockdown, cells 
were transfected with Y527F activated Src.   
(A) Western blot showing extent of knockdown; SV (top panel), transferrin receptor 
(TfR, lower panel) as a loading control.   
(B) Quantification of the percentages of cells with podosomes.   
(C) Quantification of the number of podosomes per cell.   
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20% ± 5% of endogenous levels (Figure 2-18).  The normal-looking appearance of the 
ventral F-actin structures in SV knockdown cells, coupled with the reduced numbers of 
associated ECM holes in MDA-MB-231/WT Src cells, suggest a defect in invadopodial 
function. 
 
 SV knockdown reduces invasion, but only in the context of reduced levels of 
gelsolin.   As a direct assay for the roles of SV and gelsolin in invasion, we measured the 
effects of single and double SV and gelsolin knockdowns on the ability of MDA-MB-
231/WT Src cells to invade Matrigel™-coated transwell filters (Figure 2-19).  Invasion 
indices are normalized to eliminate effects of changes in cell motility although no 
statistically significant differences are apparent in the rates of cell transmigration across 
uncoated filters at this long time point (data not shown).  Knockdown of SV alone shows 
an upward trend in invasion index (Figure 2-19), and reduction of gelsolin alone shows a 
downward trend that compares favorably with previously published results (Van den 
Abbeele et al., 2007).  However, assay-to-assay variances preclude statistical significance 
for single knockdowns of either SV or gelsolin.  By contrast, simultaneously reducing SV 
and gelsolin significantly decreases the ability of MDA-MB-231 cells to invade 
Matrigel™-coated filters.   
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Figure 2-19.  Matrigel™ invasion is decreased in cells depleted of both SV and gelsolin.   
MDA-MB-231/WT Src cells were treated with siRNAs targeting either SV (SV1, SV2), 
gelsolin (Gel), or both (SV1/Gel) and assayed for invasion through Matrigel™-coated 
filters.  Invasion indices were determined by normalizing against transmigration in the 
absence of Matrigel™ to control for changes in cell motility and by normalizing 
experimental invasion indices against the mean value obtained for cells treated with 
control siRNAs (Control).  Cells depleted in both SV and gelsolin were significantly less 
invasive than controls, based on unpaired t tests (*, p < 0.05; n = 3). 
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Discussion 
 We show here that SV reorganizes the cortical actin cytoskeleton, stimulating the 
formation or redistribution of dynamic basal punctae containing F-actin, cortactin, and 
other podosome/invadopodia proteins while decreasing the extents of cortactin and 
lamellipodin at the cell periphery.  SV and cortactin bind directly in vitro and cooperate 
to redistribute F-actin in vivo. We also show that SV is a core component of Src-induced 
podosomes and invadopodia and that SV contributes to ECM degradation and Matrigel™ 
invasion by Src-expressing MDA-MB-231 breast carcinomas.  These results are 
consistent with the report that the gene encoding SV, SVIL, is among the predisposing 
factors for non-BRCA1/2 (BRCAx) breast cancer (Hedenfalk et al., 2003). 
One possible mechanism of SV action is alteration of signaling pathways 
upstream of cytoskeletal remodeling.  The earliest change that we see in lamellipodial 
architecture in cells expressing EGFP-SV is the loss of peripheral lamellipodin (Figure 
2-6).  Lamellipodin regulates actin polymerization mediated by Ena/VASP family 
proteins downstream of Ras activation (Krause et al., 2004; Jenzora et al., 2005).  The 
lack of extensive overlap between lamellipodin and SV in punctae argues against a direct 
interaction between these two proteins.  However, an indirect negative effect of SV on 
lamellipodial organization at the cell periphery could lead to the loss of broad arcs of 
peripheral F-actin, cortactin, and lamellipodin that we observe (Figure 2-5, 2-6).  
A second possibility is that SV-induced punctae may represent 
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podosome/invadopodia “building blocks” associated with vesicles and/or molecular 
motors at various stages of assembly or intracellular transit.  SV may help recruit 
cortactin and F-actin to intracellular membranes. Because SV, cortactin and filamin all 
bind F-actin, the lack of filamin recruitment to punctae argues for a selective association 
with cortactin.  A membrane-based mechanism for SV is likely based on its intracellular 
distribution and fractionation behavior (Pestonjamasp et al., 1997; Wulfkuhle et al., 
1999; Nebl et al., 2002; Oh et al., 2003; Takizawa et al., 2006).  The dot-like 
appearances of many EGFP-SV punctae (Figure 2-1, 2-4) and X-Y views of endogenous 
SV at podosomes (Figure 2-8) are reminiscent of vesicles, as are the circular profiles that 
are occasionally apparent for larger structures associated with EGFP-SV (Figure 2-3, 
Video 1).  EGFP-SV/F-actin/cortactin punctae also resemble cortactin structures 
described as appearing prior to actin recruitment in phorbol ester-induced podosomes 
(Webb et al., 2006a) or originating at lamellipodia and moving in association with 
endosomes (Kaksonen et al., 2000; Boguslavsky et al., 2007; Lladó et al., 2008).  
Although we did not detect consistent directional trafficking of SV punctae from the cell 
periphery to the basolateral cell surface, subtle effects on vesicle trafficking or on 
cortactin recruitment to transport vesicles could lead to the observed shift in cortactin and 
F-actin distribution over time.    
 A selective effect of SV on basolateral targeting of cortactin and MMPs would be 
consistent both with the observed effects of SV knockdown on sites of matrix 
degradation under the cell center (Figure 2-17) and with the role of cortactin in MMP 
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trafficking and matrix degradation (Bowden et al., 1999; Artym et al., 2006; Clark et al., 
2007; Clark and Weaver, 2008).  Cortactin recruitment to the ventral cell surface occurs 
in stages, mediated by at least three convergent regulatory signals (Artym et al., 2006; 
Webb et al., 2006a; Ayala et al., 2008).  Activating mechanisms include cortactin 
phosphorylation by ERK1/2, Src family kinases, and PAK (Webb et al., 2006b; Tehrani 
et al., 2007; Ayala et al., 2008).  In this context, we note that an isoform of SV is 
involved in stimulus-mediated activation of ERK1/2 in smooth muscle (Gangopadhyay et 
al., 2004), and that SV binds directly to and regulates myosin II (Takizawa et al., 2007), 
which directly affects exocytosis in a number of cell types (Togo and Steinhardt, 2004).  
The sequential regulated recruitment of MMPs and other proteins to invadopodia 
suggests that subsequent matrix degradation is a dynamic multi-step process (Artym et 
al., 2006; Clark et al., 2007; Block et al., 2008).  Our SV knockdown results (Figure 2-
17) are consistent with SV-mediated increases in cortactin activation, enhanced cortactin- 
or myosin II-mediated MMP secretion, and/or elevation of the rate of invadopodia 
turnover. 
The decreased matrix degradation generated by knockdowns of either SV, 
cortactin or Tks5 and the co-localization of all three proteins at SV-induced punctae 
suggests functional cooperation (Seals et al., 2005; Artym et al., 2006; Clark et al., 2007; 
Webb et al., 2007; Ayala et al., 2008; Clark and Weaver, 2008).  Participation in a 
common pathway is further supported by the interaction of SV with cortactin and by the 
decreased formation of EGFP-SV induced F-actin punctae in cortactin knockdown cells 
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(Figure 2-7).  Thus, these proteins may cooperate in signaling and/or cytoskeletal 
organization during invadopodia formation.  However, F-actin structures form at Src-
induced podosomes and at the ventral surfaces of MDA-MB-231 cells after SV 
knockdown, arguing for SV-independent effects during initial cytoskeletal assembly.   
 Our results support the hypothesis that SV promotes the loss of large central focal 
adhesions (Takizawa et al., 2006) by increasing local matrix degradation.  The effects of 
SV overexpression on large focal adhesions and on ECM degradation both represent a 
gain of function because reduction of endogenous SV exhibits the opposite phenotype 
(Takizawa et al., 2006, Figures 2-14, 2-17).  SV targeting to focal adhesions by binding 
to TRIP6 (Takizawa et al., 2006) could lead to a loss of underlying matrix, causing 
detachment of integrins and thereby inducing focal adhesion disassembly.   
 Surprisingly, we find that the outcomes of gelatin degradation experiments with 
SV and gelsolin (Figure 2-17) do not predict the results of MatrigelTM invasion assays 
(Figure 2-19).  This might be due to the fine line between degrading enough ECM for 
transmigration vs. destroying too much underlying matrix for the adhesion necessary for 
movement. These observations are consistent with the report that down-regulation of 
MT1-MMP can actually increase invasion (Partridge et al., 2007).  The long time courses 
of invasion assays also allow for other mechanisms, such as alterations in cell motility or 
proliferation, in response to the growth factors that can be released from MatrigelTM 
(Kleinman and Martin, 2005). Commonalities in signaling mechanisms could explain the 
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functional redundancy between SV and gelsolin during MatrigelTM invasion, especially if 
SV can recruit actin to membranes enriched in PIP2, as suggested by the similarities 
between SV and gelsolin sequences involved in this process (Hartwig et al., 1989; Mere 
et al., 2005). Gelsolin and CapG, another member of the villin/gelsolin family, also 
synergize with each other during matrix invasion and have each been implicated in 
multiple stages of tumorigenesis (Dong et al., 1999; Lee et al., 1999; Silacci et al., 2004; 
Watari et al., 2006; Kim et al., 2007; Van den Abbeele et al., 2007; Nomura et al., 2008).  
We conclude that SV plays a nonredundant role in ECM degradation by MDA-MB-231 
breast carcinoma cells and has a function overlapping that of gelsolin during invasion, 
both of which are important facets of tumor cell migration and metastasis.  
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Chapter III 
 
 
 
 
 
Supervillin and Cytoskeleton-Associated 
Detergent Resistant Membranes 
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Abstract 
One property of membrane rafts is resistance to extraction with cold Triton X-100 
and flotation to low buoyant densities.  The actin cytoskeleton is implicated in membrane 
raft signaling, but interactions between actin and raft components are not well 
characterized.  Our laboratory isolated a detergent resistant membrane fraction, called 
DRM-H, that contains ~23 neutrophil plasma membrane proteins (Nebl et al., 2002).  
DRM-H is rich in cytoskeletal proteins, including fodrin, actin, myosin II, and the F-
actin- and myosin II-binding membrane protein supervillin.  DRM-H also contains the 
raft organizing proteins flotillin and stomatin, and signaling proteins, including Lyn 
kinase, a Src family member, and heterotrimeric G protein subunits.  DRM-H exhibits a 
higher buoyant density (d ~1.16 g/ml) than do most DRMs (d = 1.09-1.13), which are 
deficient in cytoskeletal proteins.  I hypothesize that DRM-H represents cytoskeleton-
associated membrane rafts and is involved in trafficking and/or signaling in many cell 
types.  As confirmation for this hypothesis, I find that in COS-7 cells, supervillin, the 
most tightly bound cytoskeletal protein in neutrophil DRM-H, co-localizes with c-Yes, a 
Src family kinase and raft protein, at membrane clusters.  Domain analysis of supervillin 
suggests that a major membrane-binding site is located within amino acids 830 – 1010.  
COS-7 cells also contain cytoskeleton-associated DRMs.  Following detergent extraction, 
flotillin-2 and c-Yes distribute in at least two peaks.  Fodrin (non-erythroid spectrin) and 
supervillin co-migrate with the denser peaks of flotillin-2 and c-Yes in sucrose gradients, 
using both flotation and sedimentation methods.  In addition, when transfected into COS-
7 cells, estrogen receptor (ER)α associates with DRM-H, while ERβ is seen in both 
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DRM-L and DRM-H populations, suggesting a role for DRM-H in non-genomic estrogen 
signaling.  Taken together, these results demonstrate that the cytoskeleton-associated 
DRM-H not limited to hematopoietic cells and could constitute a scaffold for membrane 
raft-cytoskeleton signaling events in many cells. 
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Introduction 
Crucial to the cell’s ability to move is the proper organization and 
compartmentalization of the plasma membrane.  One method cells use to organize the 
plasma membrane is the formation of liquid-ordered membrane domains, or membrane 
rafts.  Membrane rafts, also known as lipid rafts, are defined as “small (10-200 nm), 
heterogeneous, highly dynamic, sterol- and/or sphingolipid-enriched domains that 
compartmentalize cellular processes.  Small rafts can sometimes be stabilized to form 
larger platforms through protein-protein and protein-lipid interactions” (Pike, 2006).  
Proteins can be targeted to rafts by lipid modification, including addition of a myristoyl 
or palmitoyl moiety (Melkonian et al., 1999; Zacharias et al., 2002) or a 
glycosylphosphotidylinositol (GPI)-anchor (Brown and Rose, 1992). Rafts participate in 
many membrane-initiated signaling events as well as trafficking and sorting of proteins 
and virus particles (reviewed in (Edidin, 2003)).   
Participation of the actin cytoskeleton has been implicated in many membrane raft 
mediated signaling processes. This has been especially well studied in many immune 
cells (Viola and Gupta, 2007).  Membrane rafts are concentrated to form the 
immunological synapse in T cells at the interface with antigen presenting cells (Viola et 
al., 1999), and the actin cytoskeleton is key to synapse formation (Monks et al., 1998). 
Disruption of the actin cytoskeleton by cytochalasin B inhibits raft clustering in Jurkat T 
cell line (Villalba et al., 2001).  Filamin A, an actin crosslinking protein, is responsible 
for the movement of the co-stimulatory molecule CD28 into the raft 
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compartment/immunological synapse (Tavano et al., 2006), and filamin A knockdown 
also disrupts membrane raft accumulation at the synapse (Tavano et al., 2006).  It is 
thought that filamin A “tethers and traps” membrane rafts at the synapse, as opposed to 
the case in B cells where ezrin (a membrane/actin linker protein) dissociates from rafts 
upon B cell receptor engagement (Gupta et al., 2006), perhaps leading to an 
“untethering” of rafts from the actin cytoskeleton (Viola and Gupta, 2007). In mast cells, 
the actin cytoskeleton is implicated in downregulation of IgE receptor signaling by 
providing tracks for Lyn kinase to move away from the raft-resident receptor (Holowka 
et al., 2000).  From these studies, as well as others, it is clear that the cytoskeleton is vital 
to membrane raft processes.  However, many details of the interactions between raft 
components and the cytoskeleton remain to be elucidated.  
One particular kind of membrane raft, caveolae, are organized by cholesterol 
binding proteins called caveolins (Thomas and Smart, 2008) and are sites of nongenomic 
signaling of estrogen receptors (ER) (Razani et al., 2000; Sak and Everaus, 2004). Aside 
from its canonical role in nuclear signaling, estrogen can rapidly alter cell signaling 
through calcium release, mitogen-activated protein (MAP) kinase and 
phosphatidylinositol 3-kinase (PI3K) pathways, suggesting a role in signal transduction at 
the membrane in so-called ‘nongenomic’ signaling (Morley et al., 1992; Le Mellay et al., 
1997; Migliaccio et al., 1998; Bjornstrom and Sjoberg, 2005).  The membrane receptor 
that initiates these signals is debated, but both ERα and ERβ, traditional nuclear ERs, can 
localize to the plasma membrane (Razandi et al., 1999).  ERα can be palmitoylated at 
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cysteine 447, and this residue is important for interaction with caveolin-1, as well as for 
downstream signaling to MAPK (Acconcia et al., 2004).   That cysteine residue is 
conserved in ERβ, suggesting that this protein also may be palmitoylated (Bourguignon 
et al., 2005).  Additional research into mechanisms of nongenomic estrogen signaling 
focused on the membrane microenvironment will serve to further illuminate these 
pathways and their potential for treatment of breast cancer.   
One of the hallmarks of membrane rafts is the close packing of saturated lipid 
acyl chains, which makes these domains resistant to extraction with cold nonionic 
detergents.  This property, coupled with their relatively low buoyant density, has been 
employed to isolate membrane rafts in vitro.  Although some issues have been raised 
about this method of isolation (Shogomori and Brown, 2003), it remains a good 
biochemical starting point for understanding which proteins can be associated with such 
membrane domains.  
Our laboratory has isolated a heavy detergent resistant membrane (DRM) 
fraction, called DRM-H, that contains ~23 neutrophil plasma membrane proteins (Nebl et 
al., 2002). The DRM-H fraction exhibits a high buoyant density (~1.16 g/ml), relative to 
most DRMs (d=1.09-1.13), which are deficient in cytoskeletal proteins.  However, DRM-
H is rich in cytoskeletal proteins (fodrin, actin, myosins IG and II, vimentin, alpha-actinin 
and the F-actin- and myosin II- binding membrane protein, supervillin), as well as raft 
organizing proteins (stomatin and flotillin), signaling proteins (lyn kinase, heterotrimeric 
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G protein subunits) and the GPI-linked matrix metalloproteinase, MT-6-MMP.  When 
total DRMs are isolated from neutrophil plasma membranes and resolved by sucrose 
gradient, the membrane raft proteins, Lyn, flotillin 2, and Gαi-2, show a biphasic 
distribution, with a significant proportion co-purifying with membrane skeleton proteins 
(Figure 3-1A, B).  These membrane skeleton proteins — fodrin, SV, myosin-IG, and 
actin — peak together in high buoyant density sucrose gradient fractions (DRM-H) 
(Figure 3-1A, B). The heavy chains of myosin-IIA and clathrin are enriched in fractions 
of intermediate density (Figure 3-1A, B). In the case of the Gαi-2, SV can co-localize with 
endogenous raft proteins in isolated neutrophils (Figure 3-1D), verifying that isolated 
DRM-H components exist in complexes in vivo. 
 Most DRM preparations involve floating membranes through 30-35% sucrose 
(Brown and Rose, 1992) and discounting denser proteins as the cytoskeleton or Triton-
soluble material.  However the DRM-H complex isolated from neutrophil plasma 
membranes by our lab is, in fact, Triton-insoluble and associated with cholesterol-rich 
membranes, but its density of ~1.16 g/ml corresponds to sucrose concentrations of 37-
40%, causing these complexes to not float in ample quantity in conventional sucrose 
gradients. This may have lead other researchers to overlook DRM-H.   
Because lipid raft association with the actin cytoskeleton is crucial for many 
processes (Viola and Gupta, 2007), I hypothesize that DRM-H represents a subset of 
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membrane rafts involved in trafficking and/or signaling events at the plasma membrane 
of many, if not all, cell types. 
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Figure 3-1.  DRM-H represents a membrane skeleton-associated subset of leukocyte 
signaling domains.   
(A) Silver-stained fractions (25µg/lane) after centrifugation of neutrophil plasma 
membrane DRMs into a linear 20-45% sucrose density gradient. This gradient contains 
opalescence visualized as DRM-L and DRM-H. Arrows show positions of the proteins 
visualized by immunoblot analyses.  
(B) Immunoblot analyses of sucrose density gradient fractions. Fractions (25 µg/lane) 
from the gradient shown in (A) were blotted and probed with antibody against membrane 
skeleton (fodrin, supervillin, myosin-IG, actin, myosin-IIA), coated pit (clathrin), or lipid 
raft proteins (Lyn, flotillin 2, Gαi-2). Numbers indicate sucrose density gradient fractions 
from top (1) to bottom (16). Approximate locations are shown for the gradient load (L), 
low density DRMs (DRM-L), coated pits (CP), high density DRMs (DRM-H), and pellet 
(P).  
(C) Densities (circles) and apparent protein concentrations (triangles) of the sucrose 
gradient fractions shown in (A).  
(D) Confocal immunofluorescence images show partial co-localization of supervillin and 
Gαi-2 in peripheral micropatches of unroofed neutrophils. Neutrophils spread on poly-L-
lysine-coated coverslips were mechanically sheared and stained with antibodies against 
supervillin (green) and Gαi-2 (red).  Overlap appears yellow (Merge). Bar, 2 µm. 
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Materials and Methods 
 
Cell lines, plasmids and transfection 
COS7-2 cells, a highly transfectable clone of COS7 (Kowalczyk et al., 1997), 
were a generous gift from Dr. Kathleen J. Green (Northwestern University, IL).  COS7 
cells were grown in Dulbecco’s modified Eagle high glucose media (DMEM, Invitrogen, 
GIBCO #11995) supplemented with 10% fetal calf serum (FCS) for ≤20 passages.  Cells 
transfected with ERα or ERβ were sterol starved 24 hours prior to extraction in phenol 
red-free DMEM supplemented with 10% charcoal treated FCS.   
Plasmids encoding EGFP-SV and EGFP-tagged SV domains have been described 
(Wulfkuhle et al., 1999, Chen, 2003 #52).  The plasmid encoding EGFP-SV-830-1010 
was made cutting the EGFP-SV-830-1282 vector with EcoR1, purifying away from the 
cut fragment and ligating. Full length ERα and ERβ plasmids were kind gifts of Dr. 
Leigh C. Murphy.  COS-7 cells were transfected using Effectene Transfection Reagent 
(Qiagen Inc.) for either 24 hours for EGFP-tagged SV domains, ERα and ERβ, or for 48 
hours for full length EGFP-SV. 
Immunofluorescence 
 EGFP-SV transfected COS-7 cells were seeded onto gelatin-coated coverslips for 
24 hours, and then fixed for 10 minutes with 4% paraformaldehyde in PBS.  Cells were 
permeabilized for 5 minutes with 0.2% Triton X-100 in PBS before blocking for 30 
minutes with 1% BSA, 0.5% Tween-20 in PBS and immunostaining for c-Yes at 1:100 
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dilution (BD Transduction Laboratories). AlexaFluor 568-conjugated secondary antibody 
against mouse IgG was from Invitrogen (Carlsbad, CA) and used at 1:2000 dilution. 
Slides were analyzed with a100X Plan-NeoFluor oil immersion objective (NA 1.3) on a 
Zeiss Axioskop fluorescence microscope, a RETIGA 1300 CCD camera (QImaging), and 
OpenLab 3.5.2 software. 
Preparation of Crude Membrane Fractions 
Adherent COS-7 cells were lysed and scraped into homogenization buffer (HB, 
0.25 M sucrose, 5 mM Tris, pH 7.4, 1 mM MgCl2, (Hiol et al., 2003)) containing 1 mM 
PMSF, and a protease inhibitor cocktail (PI mix) containing: 1 mg/ml aprotinin, 1 mM 
antipain, 2 mM ALLM (calpain inhibitor II), 1 mM benzamidine, 10 mM E64, 1 mM 
leupeptin, and 1 mM pepstatin A.  Lysates were homogenized with 10 strokes of a tight-
fitting Teflon Dounce homogenizer and nuclei were pelleted by centrifugation for 5 
minutes at 3000 x g.  The precleared lysate was then subjected to a second 30-minute 
centrifugation of 20,000 x g.  The resulting pellet is referred to as the crude membrane 
fraction.  Cell equivalents of supernatant and pellet fractions were separated by SDS-
PAGE and analyzed by immunoblotting for GFP (Roche).   
Membrane “ripoffs” 
“Footprints” of cells grown on glass coverslips were obtained by directing a 
stream of 37°C PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM 
MgCl2, pH 6.9, (Hartwig et al., 1989)) from a 26 gauge needle attached to a 5 mL 
syringe.  Cell patches were immediately fixed in 2% paraformaldehyde in PHEM for 15 
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minutes, permeabilized for 5 minutes with 0.2% Triton X-100 in PBS before blocking for 
30 minutes with 1% BSA, 0.5% Tween-20 in PBS and immunostaining. F-actin was 
visualized with Texas Red phalloidin (Invitrogen).  
Preparation of DRMs 
Sedimentation Gradients 
COS-7 cells were grown on 150 mm tissue culture dishes to ~75% confluency, 
rinsed twice with ice-cold PBS, and then extracted for 15 minutes on ice with 1 ml of 
Triton extraction buffer (TEB: 1% Triton X-100, 25 mM Tris, 250 mM NaCl, 2.5 mM 
MgCl2, 1 mM EGTA, 1 mM ATP) containing protease inhibitor cocktail (see above and 
Appendix B) and 1 mM PMSF.  Cell lysate was gathered from the culture dish using a 
cell scraper, then transferred to a Dounce homogenizer. Lysates were homogenized with 
10 strokes of a tight-fitting Teflon Dounce homogenizer and nuclei were pelleted by 
centrifugation for 10 minutes at 1000 x g.  Cleared lysate (1 ml) was loaded into a 
SW55Ti ultracentrifuge tube (Beckman) atop a sucrose step gradient with the following 
steps: 0.5 ml of 10%, 1 ml of 30%, 1 ml of 40%, 1 ml of 50%, and 0.5 ml 64% sucrose in 
TEB.  Gradients were centrifuged for 16 hours at 300,000 x g.  All manipulations were 
performed on ice or at 4°C.  
Flotation Gradients 
 COS-7 cells were transfected, as indicated in figure legend, and grown to ~75% 
confluency in 150 mm tissue culture dishes.  Cells were extracted with 2 ml of 1% Triton 
X-100 in TNE buffer [(25 mM Tris, 150 mM NaCl, 5 mM EDTA) containing protease 
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inhibitor cocktail, and 1 mM PMSF, 20 µM phenylarsine oxide and 1 µM sodium 
orthovanadate] for 30 minutes, gathered from the culture dish using a cell scraper, then 
transferred to a Dounce homogenizer. Lysates were homogenized with 10 strokes of a 
tight-fitting Teflon Dounce homogenizer and nuclei were pelleted by centrifugation for 
10 minutes at 1000 x g.  1.3 g of solid sucrose was added to the cleared lysate, then 
rotated for 15 minutes to mix before adding 1 ml of saturated (64%) sucrose solution and 
rotating for an additional 5 minutes.  This sample was included in a sucrose density 
gradient with the following steps: 1 ml of 10%, 3 ml of 30%, 3 ml of 40%, 3 ml of 
sample (~50%) and 0.5 ml of 64% sucrose.  Gradients were centrifuged for 16 hours at 
200,000 x g in a Beckman SW41Ti rotor.  All manipulations were performed on ice or at 
4°C. 
Gradient fractionation and analysis 
Gradients were fractionated (300 µl) at a rate of 0.5 ml/min using a model 
640 density gradient fractionator (Isco Inc., Lincoln, NE). Aliquots were assayed for total 
protein concentration using BCA assay reagent (Pierce), for density, and for individual 
proteins by SDS-PAGE (large 6-16% polyacrylamide gradient gels) and immunoblotting. 
The densities of sucrose solutions and resulting gradient fractions were determined by 
measuring refractive indices using a model 334610 refractometer (Bausch & Lomb, 
Rochester, NY).   
Immunoblotting 
 For crude membrane preparations, equivalent fractions of initial cellular material 
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were loaded onto SDS-polyacrylamide gels (Laemmli, 1970), transferred to nitrocellulose 
membranes (Towbin et al., 1979), blocked with 5% nonfat milk in tris-buffered saline 
with 0.1% Tween-20 (TBS-T), and probed with primary antibody against GFP (0.4 
µg/ml, Roche, Indianapolis, IN).  For density gradients, equal volumes of fraction were 
analyzed by SDS-PAGE followed by immunoblotting for: supervillin (0.2 – 0.4 µg/ml); 
transferrin receptor (1 µg/ml, Zymed, San Francisco, CA); flotillin 2 (0.125 µg/ml, BD 
Transduction Laboratories, San Jose, CA); c-Yes (0.25 µg/ml, BD Transduction 
Laboratories), fodrin (0.1 µg/ml, ICN, Aurora, IL); ERα (1 µg/ml clone D12, Santa Cruz 
Biotechnology, Santa Cruz, CA); and ERβ (5 µg/ml, GeneTex, San Antonio, TX).  HRP-
conjugated goat anti-mouse or goat anti-rabbit secondary antibodies (Jackson 
Laboratories, West Grove, PA), diluted 1:20,000, were detected by SuperSignal 
WestPico chemiluminescence (Pierce).  
Detection of GM1 ganglioside 
 The relative amounts of the GM1 ganglioside were determined as described 
(Dolganiuc et al., 2003).  Briefly, an Immobilon-P membrane was rinsed with methanol, 
followed by dH2O, and then PBS. Dot blots were made by spotting 10 µl of each gradient 
fraction onto the pre-treated membrane using the Easy Titer ELIFA system (Pierce).  
Membranes were allowed to dry overnight, then blocked with 5% nonfat milk in TBS-T 
and incubated with the peroxidase-conjugated cholera toxin B (0.25 µg/ml) for 30 
minutes each.  Signal was visualized with SuperSignal West Pico chemiluminescence 
(Pierce).   
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Results 
EGFP-SV co-localizes with some clusters of c-Yes.  To investigate a potential 
relationship between the DRM-H marker protein, SV, and membrane rafts in COS-7 
cells, I first utilized microscopy.  Because typical membrane raft sizes are below the limit 
of light microscopy (Varma and Mayor, 1998; Pralle et al., 2000), I plated EGFP-SV 
transfected COS-7 cells on a gelatin-coated coverslip in an effort to stimulate the cells 
and cluster individual rafts.  Immunostaining for c-Yes, a Src-family kinase predominant 
in COS-7 cells, revealed several clusters, some of which co-localized with EGFP-SV; in 
other clusters, EGFP-SV was noticeably absent (Figure 3-2).  Upon closer inspection, the 
c-Yes clusters are punctate structures (Figure 3-2, inset); the EGFP-SV does not overlap 
perfectly with the c-Yes punctae, but clusters within the same boundaries.  Thus, SV can 
associate in the same structures as lipid raft proteins in vivo.   
 
Primary membrane targeting site of SV lies within amino acids 830-1010; secondary 
sites may exist in N- and C- termini.  To determine the membrane interaction domain(s) 
in SV, I expressed a series of EGFP-tagged versions of SV domains in COS-7 cells and 
fractionated these cells into membrane pellets (P) and cytoplasmic supernatants (S). 
Analysis by SDS-PAGE followed by immunoblotting shows strong membrane targeting 
of EGFP-SV-830-1010 (Figure 3-3A).  The association of EGFP-SV-830-1010 with the 
membrane pellet is specific to the full-length construct, because apparent breakdown 
products remain in the supernatant. By the size of the breakdown product I can estimate 
that the last ~45 amino acids are essential for binding, narrowing the SV membrane 
 78 
 
 
Figure 3-2.  EGFP-SV co-distributes in some, but not all, c-Yes rich structures. 
EGFP-SV transfected COS-7 cells (left panel, green in Merge) were plated on gelatin 
coated coverslips and immunostained with c-Yes antibody (center panel, red in Merge).  
Some of the c-Yes clusters are associated with EGFP-SV (arrow, inset); others are not 
(arrowhead).  Insets enlarged 7-fold.  Bar, 20 µm. 
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association domain to amino acids  ~965-1010.  By fluorescence and light microscopy, I 
observe punctate EGFP-SV-830-1010 co-localizing with phase dense particles (Figure 3-
3B), which may represent vesicles from the sheared membrane.  In addition, EGFP-SV-
830-1010 remains with the cell “footprint” on the coverslip without detectable F-actin 
after physical disruption of intact cells (Figure 3-3C), suggesting that EGFP-SV-830-
1010 association with the plasma membrane is independent of F-actin, as expected given 
that the characterized actin-binding sites in SV lie outside of this sequence.  
While EGFP only shows no association with the membrane pellet, EGFP-SV-1-
830 is moderately associated, and EGFP-SV-1010-1792 shows a small amount of 
membrane association (Figure 3-3A).  In a similar experiment, EGPF-SV-1-171 is also 
observed in the membrane pellet (data not shown), suggesting that the extreme N-
terminus of SV can also potentiate binding to membranes.  Thus, SV may have multiple 
modes of membrane targeting, as is the case for other lipid raft proteins (Resh, 1999, 
2004). 
In a preliminary experiment with the isolated crude membranes, both EGFP-SV-
1-830 and EGFP-SV-830-1010 resist extraction with cold 1% Triton X-100, while much 
of the EGFP-SV-1010-1792 is extracted from the membrane pellet (data not shown).  
This suggests that the membrane targeting sequences in SV may also direct the protein to 
lipid rafts.   
 
COS-7 cells have complexes similar to DRM-H in neutrophils.  DRM-H fractions can 
be isolated from COS-7 cells using a protocol similar to that used with neutrophils  
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Figure 3-3.  Primary membrane targeting site of SV lies within amino acids 830-1010; 
secondary sites may exist in N- and C- termini. 
(A)  Precleared lysates from COS-7 cells transfected with the indicated EGPF-tagged 
constructs of supervillin domains were separated into a crude membrane pellet (P) and 
supernatant (S) by a 20,000 x g spin.  
(B)  Crude membrane fractions from EGFP-SV-830-1010 transfected COS-7 cells on 
poly-L-lysine coated coverslips were imaged for green fluorescence (left panel) and 
phase contrast (right panel).  Arrows indicate examples of areas of membrane associated 
EGFP-SV-830-1010 that co-localize with phase dense particles.   
(C)  EGFP-SV-830-1010 (left panel) remains attached to the coverslip even without 
detectable F-actin (center panel).  Image of  “unroofed” COS-7 cell expressing EGFP-
SV-830-1010.  Remaining cell footprints were stained for F-actin with Texas red 
phalloidin.   Bar, 10 µm. 
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(Figures 3-4, 3-5).  First, I investigated the density gradient profile of COS-7 cell SV, a 
tightly associated DRM-H marker in neutrophils (Nebl et al., 2002), when sedimented 
into a sucrose gradient. COS-7 cells extracted in cold 1% Triton X-100 were loaded at the 
top of a sucrose step gradient, centrifuged for 16 hours at 300,000 x g, fractionated and 
analyzed by immunoblots (Figure 3-4). SV peaks in these gradients at densities ranging 
from 1.12 to 1.17 g/ml, in accordance with our results with neutrophil DRM-H.  
Additional SV signal is seen toward the bottom of the gradient, which probably 
corresponds to the purely cytoskeletal (as opposed to membrane cytoskeletal) population.  
The presence of different biochemical classes of SV in the density gradient corresponds 
well with the varying localizations I see in the cell (Figure 3-2).  Fodrin (non-erythroid 
spectrin) co-migrates with SV in the gradient. c-Yes and flotillin-2 are lipid raft resident 
proteins, and accordingly are seen predominantly at DRM-L densities, with relatively 
smaller amounts at DRM-H densities. Surprisingly, the transferrin receptor (TfR) also 
peaks in the DRM-H fractions.  TfR is a supposed non-lipid raft protein (Harder et al., 
1998), although TfR2 has been reported in low-density membrane domains with caveolin 
1 (Calzolari et al., 2006). Complexes were most likely at equilibrium density because the 
gradient profile looks similar for many marker proteins after 42 hours (data not shown). 
In this case there may have been insufficient detergent solubilization leading to TfR 
association with lighter membrane fractions.   
Although these results obtained by sedimentation into density gradients are 
consistent with the existence of DRM-H in COS-7 cells, it is not certain that these 
membrane complexes are completely separated from other protein complexes moving  
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Figure 3-4. SV co-sediments with fodrin in a heavy DRM fraction in COS-7 cells, 
similar to the density of DRM-H in neutrophils.   
COS-7 cells were extracted with TEB, and the lysate was sedimented into a sucrose 
gradient.  Gradient fractions were analyzed by SDS-PAGE followed by immunoblotting 
for fodrin, SV, c-yes, flotillin 2, and TfR, as indicated. Densities of fractions are shown in 
g/mL (bottom row).   
Approximate locations, based on density, of Triton soluble proteins (load), DRM-L, 
DRM-H and the cytoskeleton are shown.  
The majority of SV signal lies within DRM-H densities; additional, less intense signals 
are found in DRM-L and the cytoskeleton.   
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Figure 3-5.  COS-7 cell DRM-H is also apparent upon flotation through sucrose 
gradients.     
Profile of sucrose density gradient in which COS-7 cells, extracted in cold 1% Triton-X-
100 in TNE, were loaded at the bottom of the gradient and centrifuged overnight for 
complexes to reach equilibrium density. Equal volumes of gradient fractions were 
analyzed by SDS-PAGE followed by immunoblotting for SV, myosin IIB (MyoIIB), 
transferrin receptor (TfR), c-Yes, and flotillin 2 (Flot2) and dot blot for ganglioside GM1, 
as indicated.  Densities of fractions are shown in g/mL (top row). Approximate locations 
of input (Load) and DRM-L, DRM-H are shown.  
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down the gradient.  For additional confirmation of DRM-H in COS-7 cells, I examined 
whether SV and the other cytoskeleton and lipid raft markers would float to appropriate 
DRM-H density when loaded at the bottom of a sucrose gradient (Figure 3-5).  As in the 
case with neutrophil plasma membranes, two peaks of DRMs are apparent with many of 
the lipid raft markers, including c-Yes, flotillin 2 and the ganglioside GM1: a lighter peak 
(DRM-L) with densities of 1.09-1.11 g/ml and a denser peak (DRM-H) with densities of 
1.14-1.17 g/ml.  SV and myosin IIB mark both DRM populations, but greater intensity is 
evident in DRM-H.  Interestingly, TfR does not isolate to DRM-H densities in this 
gradient, which was done with increased amounts of detergent (Figure 3-5).  Together 
these experiments demonstrate that cytoskeletal-associated light membrane complexes, 
DRM-H, exist in cells other than bovine neutrophils.   
 
Estrogen receptors α  and β  both isolate with DRM-H.  The studies that connected 
ERα and ERβ to lipid rafts and DRMs did not differentiate between DRM-L and the 
cytoskeletally associated DRM-H.  I investigated the possibility of differential targeting 
by isolating DRMs from ERα- and ERβ-transfected COS-7 cells (Figure 3-6). Indeed, I 
see that some ERα floats to the DRM-H density of 1.17 g/ml with the peak of SV 
(Figure 3-6A).  In these experiments, I cannot detect ERα in the DRM-L fraction.  This 
could be due to many factors.  The level of ERα seen floating into the gradient is a very 
small percentage of the amount remaining in the load.  Therefore, COS-7 cells may be 
limited in necessary factors to target all of the exogenously expressed ERα to the proper 
compartment.  Alternatively, ERα could have a higher affinity for proteins that 
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preferentially distribute to DRM-H, including SV, which may be relatively more 
abundant in COS-7 cells.  In this context, I note that ERα interacts with SV in a yeast 
two-hybrid assay (Ting et al., 2002). ERβ, on the other hand, seems to be equally 
distributed between DRM-L and DRM-H fractions (Figure 3-6B).  Based on these 
results, I hypothesize that DRM-H could serve as a scaffold for nongenomic estrogen 
signaling events at the membrane.   
The bulk of both exogenously expressed proteins remain at the bottom of the 
gradient.  A study by Razandi, et al. determined that transfection of ERα into an ER-
negative breast cancer cell line resulted in only ~5% plasma membrane localization 
(Razandi et al., 2003).  Additional studies indicate that other intracellular populations 
exist in the mitochondria and the endoplasmic reticulum (Govind and Thampan, 2003; 
Chen et al., 2004).  Thus, it is not surprising that the majority of ERα and ERβ do not 
float in these assays. 
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Figure 3-6.  Some ERα associates with DRM-H; some ERβ associates with both DRM-L 
and DRM-H.   
Gradient profiles of COS-7 cells extracted with cold 1% Triton after transfection with (A) 
ERα or (B) ERβ for 24 hours.  Aliquots of gradient fraction (100 µl) were analyzed by 
SDS-PAGE followed by immunoblotting for SV, c-yes, flotillin 2, and TfR, as indicated. 
Densities of fractions are shown in g/mL (bottom row).   
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Discussion 
I show here that a DRM-H fraction similar both in composition and buoyant 
density to the DRM-H complex first isolated from neutrophil plasma membranes (Figure 
3-1, (Nebl et al., 2002)) exists in COS-7 cells (Figures 3-4, 3-5).  In addition, SV, a 
protein shown to be proximal to the membrane in the neutrophil DRM-H fraction, co-
distributes with the membrane raft marker, c-Yes, in these cells (Figure 3-2).  I have 
identified a strong membrane interaction domain in SV-830-1010 as well as weaker 
interaction domains in the amino- and carboxy-termini (Figure 3-3).  Additional data 
show ERα associates with DRM-H, while ERβ is seen in both DRM populations (Figure 
3-6), suggesting a role for DRM-H in non-genomic estrogen signaling.  
These studies have provided some preliminary data for SV membrane targeting 
domains.  While I have identified some membrane interaction domains in SV (Figure 3-
3), it is likely that these membrane preparations contain associated cytoskeletal proteins, 
making it possible that membrane binding is indirect.  However, the SV fragment that 
showed the strongest association with crude membranes does not contain any of the three 
F-actin binding domains, or the myosin II, L-MLCK, cortactin or TRIP6 binding sites 
within SV-1-830, suggesting that this assay is reflective of binding to another protein or 
lipid tightly associated with the plasma membrane.  Liposome binding assays will be 
necessary to further characterize the membrane binding domains of SV.  In addition, the 
raft association domain of SV was not determined.  In my hands, EGFP alone floated to 
DRM-L densities, making DRM association of all other EGFP-SV constructs suspicious.  
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EGFP can aggregate, leading to association with membrane rafts.  Monomeric-GFP 
(Zacharias et al., 2002) or other, non-raft epitope tags could be used in future studies to 
determine the SV raft association site. 
The membrane raft field has been somewhat controversial (Lai, 2003; Munro, 
2003; Nichols, 2005; Hancock, 2006), in part due to the relationship of isolated DRMs 
and membrane rafts.  DRM analysis can contribute to identification of components, but it 
is not a substitute for careful in vivo studies of membrane rafts (Edidin, 2003; 
Lichtenberg et al., 2005).  Detergent treatment of membranes can result in artificial 
clustering of rafts (Heerklotz, 2002), or loss of proteins that do interact with rafts.  One 
study documented 2-3 fold increases in the amount of a GPI-linked protein isolated in 
DRMs compared to the raft fraction determined by fluorescence correlation spectroscopy 
in model membranes (Kahya et al., 2005). Another caveat to the bulk biochemical 
isolation of DRMs is that proteins that co-isolate in the sucrose gradient may have 
originated from distinct regions of the cell (Gomez-Mouton et al., 2004). A better method 
of studying membrane rafts is tracking multiple protein movements simultaneously with 
fluorescence correlation spectroscopy.  However, the in vivo tools available for 
membrane raft analysis require specific proteins to be known.  Identification of proteins 
purified in DRM purification can be used a guideline for designing experiments linking 
the co-isolating proteins in vivo. 
 Since our first paper describing DRM-H (Nebl et al., 2002), other studies have 
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found roles for DRM-H in various signaling processes. Newcastle disease virus proteins 
associate with DRM-H fractions in transfected (Dolganiuc et al., 2003) and virus-infected 
(Laliberte et al., 2006; Laliberte et al., 2007) cells, and raft association has a role in 
infectivity of released virus.  The tumor suppressor merlin shifts from a DRM-H to 
DRM-L-density when acting in its growth suppressive mode; the loss of Triton-
insolubility in neurofibromatosis-2 patients with merlin mutations supports the potential 
significance of membrane raft association (Stickney et al., 2004).  Lectins on the surface 
of the parasitic protozoan Entamoeba histolytica, the causative agent of amoebic 
dysentery, are present in DRM-H fractions, and raft integrity is necessary for fluid-phase 
pinocytosis and adhesion to host cell monolayers, both important virulence factors 
(Laughlin et al., 2004). In addition, the DRM-H proteins fodrin, supervillin, myosin II, 
vimentin, and actin were found by proteomic analysis to co-isolate with T-cell DRMs 
(von Haller et al., 2001). 
Breast cancers that have gone into remission after antiestrogen treatment often 
relapse after 12-18 months.  One hypothesis is that cancer cells undergo biochemical 
changes that allow them to adapt to lower estrogen levels.  This ‘adaptive 
hypersensitivity’ to estrogen is thought to occur through nongenomic signaling (Santen et 
al., 2004).   Although debate exists over the plasma membrane receptor for estrogen, both 
ERα and ERβ interact with membrane rafts (Chambliss et al., 2002; Acconcia et al., 
2005a).  However, estrogen elicits different responses when signaling through ERα vs. 
ERβ (Acconcia et al., 2005b).  Lateral compartmentalization in the membrane, possibly 
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represented by the different amounts in of each receptor in DRM-L vs. DRM-H seen in 
these preliminary experiments, could account for the differences in signaling.  In vivo 
functional studies will determine if there is a role for SV, or other DRM-H proteins in 
nongenomic signaling.   
Taken together, I conclude that cytoskeleton-association with membrane rafts, 
biochemically isolated as DRM-H, is a widespread phenomenon that participates in 
numerous signaling pathways.   
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Chapter IV 
 
General Discussion 
At the beginning of my dissertation, SV was known to be an actin-binding 
peripheral membrane protein that partially co-localized with focal adhesions, but little 
was known about its function.  Work presented in this dissertation elucidates a function 
for SV in matrix degradation at invadopodia (Chapter II). We also show that SV is 
closely affiliated with a population of cytoskeleton-associated DRMs (DRM-H) that is 
found in neutrophils (Nebl et al., 2002), COS-7 cells (Chapter III), and possibly skeletal 
muscle ((Oh et al., 2003), Appendix A).  DRM-H may represent a subset of membrane 
rafts that integrate membrane signaling with the underlying actin cytoskeleton.  The 
presence of ERα and ERβ in DRM-H suggest a role in nongenomic estrogen signaling.  I 
have also determined that SV binds to the S2 regulatory region of myosin II ((Chen et al., 
2003), Appendix A), helping to change the view of SV from an actin-binding focal 
adhesion protein to a myosin regulatory protein.  During the course of my thesis, my 
colleagues in the lab have expanded on this, showing SV regulation of myosin II during 
cell spreading by interacting with the long form of myosin light chain kinase (Takizawa 
et al., 2007).  The myosin II-binding site in SV that I identified also regulates focal 
adhesion integrity, presumably through a similar enhancement of myosin II contractility 
(Takizawa et al., 2006).   
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SV induced F-actin punctae 
SV localizes to and regulates focal adhesions (Wulfkuhle et al., 1999; Takizawa 
et al., 2006).  However, the F-actin punctae induced by EGFP-SV in COS-7 cells are 
decidedly distinct from focal adhesions (Chapter II).  The presence of the 
podosome/invadopodia marker proteins, cortactin, Tks5 and cdc42 in these punctae, 
coupled with their dynamic nature and the ability, in some cases, to localize over areas of 
matrix degradation lead to the hypothesis that these structures may represent 
podosome/invadopodia “building blocks”.  Consistent with findings on podosomes and 
invadopodia (Artym et al., 2006; Zhou et al., 2006; Clark et al., 2007), the formation of 
SV punctae is partially blocked by cortactin knockdown (Figure 2-7).  
In an effort to understand other contributing pathway(s) involved in the formation 
of SV punctae, I hypothesized that these punctae are podosome-like structures and/or 
podosome/invadopodia precursors.  Therefore, I attempted several co-expression and 
drug treatment experiments that affect podosome/invadopodia formation.  First, I co-
transfected EGFP-SV and two cortactin truncation mutants that interfere with actin 
polymerization during podosome formation (Webb et al., 2006a) to determine if punctae 
formation was affected.  The C-terminus of cortactin (C-cort), which lacks the ability to 
bind actin and Arp2/3, but retains N-WASp binding, inhibits podosome formation in 
smooth muscle cells.  Full length cortactin with a point mutation eliminating N-WASp 
binding has no effect on the percentage of cells with podosomes, but drastically reduces 
the number of podosomes per cell in smooth muscle cells (Webb et al., 2006a).  Both 
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constructs co-localized slightly with, but did not eliminate the formation of, EGFP-SV 
induced punctae (data not shown).  However, given that there was only a partial decrease 
in punctae formation following cortactin knockdown (Figure 2-7), the results with the 
cortactin mutants should be similarly quantified.  N-WASp is an important activator of F-
actin assembly at podosomes and invadopodia(Mizutani et al., 2002; Yamaguchi et al., 
2005a).  Therefore, I co-expressed mRFP-SV and dominant negative EGFP-N-WASp-
∆A that lacks Arp2/3 binding (Magdalena et al., 2003). SV punctae still formed in the 
presence of this construct (data not shown).  However, I’m not confident that N-WASp is 
not involved because this construct also allowed formation of Src-induced podosomes, 
which are dependent on N-WASp (Linder and Aepfelbacher, 2003).   I also saw that 
EGFP-SV punctae formation was not inhibited by co-expression of dynamin2-K44A (gift 
of Mark McNiven, Mayo Clinic), a dominant negative form of the membrane bound 
GTPase that inhibits actin turnover at podosomes (Ochoa et al., 2000) and matrix 
degradation at invadopodia (Baldassarre et al., 2003).  Inhibition of Src, a key signaling 
molecule in podosome and invadopodia formation (Buccione et al., 2009), by co-
transfection of dominant negative Src(Y527F/K295R) (gift of Steve Hanks, Vanderbilt 
University), or treatment with PP2 Src inhibitor also did not prevent EGFP-SV punctae 
formation (data not shown).  Although these experiments should be carefully quantified 
to be more conclusive, they suggest that multiple, partially redundant pathways may 
contribute to SV punctae formation, similar to the multiple inputs described for 
invadopodia formation (Ayala et al., 2008). 
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SV role in Src-induced podosome formation 
Knockdown experiments suggest that SV is not required for podosome formation 
in COS-7 cells expressing constitutively active Src (Figure 2-18).  Because siRNA 
treatment does not completely eliminate SV (~10% of SV remains), I also simultaneously 
investigated whether dominant negative SV constructs would interfere with podosome 
formation.  In addition to its F-actin-binding site, EGFP-SV-342-570 binds to TRIP6 and 
negatively regulates stress fibers and focal adhesions (Takizawa et al., 2006). EGFP-SV-
∆342-570 lacks this domain, and is largely absent from focal adhesions.  EGFP-SV-∆1-
171 lacks the myosin II binding domain.  When co-transfected with constitutively active 
Src, these constructs all allow podosome formation (data not shown).   The signal to form 
podosomes by constitutively active Src is very strong.  In fact, I tried to inhibit 
constitutively active Src in COS-7 cells with 100 µM PP2.  After 1 hour, cells still 
contained numerous podosomes, even though podosome lifetime is 2-12 minutes (Evans 
et al., 2003).  Therefore, SV may be acting upstream of Src, or the dominance of 
constitutively active Src may mask any contribution from SV.  In addition, podosome 
dynamics were not examined in SV knockdown or dominant negative SV cells.  If SV 
plays an analogous role in podosomes as it does in focal adhesions, it could affect 
structure turnover.  It is also important to note that in MDA-MB-231 cells, SV 
knockdown affected matrix degradation, but not the formation of F-actin rich structures 
on the ventral cell surface.  This supports a role for SV in the function of 
invadopodia/podosomes, but not in the initial formation of the actin structure.   
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SV effects on invadopodia function 
In this work, we demonstrate that SV functions in the efficient matrix degradation 
at invadopodia (Chapter II, (Crowley et al., 2008)), likely through its interaction with 
cortactin.  However, more work is needed to reveal the full mechanism of SV action at 
invadopodia.  Experiments that determine at which timepoint SV acts in invadopodia 
formation could contribute our mechanistic understanding.  Four stages of invadopodia 
formation have been described (Artym et al., 2006).  First, there is the appearance of 
cortactin and F-actin at the invadopodial initiation site.  The preinvadopodia stage (Stage 
II) is marked by the appearance of MT1-MMP, with additional accumulation of  cortactin 
and F-actin.  A mature invadopodia (Stage III) begins degrading matrix.  In late stage 
invadopodia (Stage IV), cortactin and F-actin diffuse but MT1-MMP remains and can 
continue matrix degradation.  Based on the presence of ventral F-actin clusters in SV 
knockdown cells without accompanying matrix degradation, it is likely that SV functions 
at a later stage in invadopodia formation (Figure 2-17).  It is not clear if the ventral F-
actin structures seen are stalled invadopodia initiation sites (Stage I) or preinvadopodia 
(Stage II).   
To determine at which stage SV affects invadopodia function, two approaches 
could be taken.  First, one could take advantage of an invadopodia synchronization 
technique described by the Buccione laboratory (Ayala et al., 2008).  In brief, cells are 
plated on a gelatin substrate, but their degradative capacity is inhibited by the synthetic 
reversible broad-spectrum metalloprotease inhibitor batimastat (BB94).  Cells can be 
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transfected with plasmids or siRNA, and incubated for up to 96 hours in the presence of 
the inhibitor.  When the cells are expressing the desired target protein or have 
downregulated a protein of interest, the inhibitor is washed out and cells can resume 
normal matrix degradation. At a fixed timepoint following drug washout, SV knockdown 
cells could be stained for cortactin and MT1-MMP, and amounts of cortactin clusters 
with and without associated MT1-MMP and localized matrix degradation could be 
quantified.  I would expect SV knockdown to increase the number of invadopodial 
initiation sites (Stage I invadopodia) compared to control, and SV overexpression to 
decrease the relative amount of Stage 1 invadopodia by increasing the efficiency of MT1-
MMP targeting to invadopodia.  This system could also be used to determine the 
domain(s) of SV necessary for matrix degradation at invadopodia by transfection of a 
series of SV domain constructs after SV knockdown.   
Another technique that could elucidate SV effects on invadopodia is live cell 
imaging.  Based on my results of SV overexpression in MDA-MB-231 cells (Figure 2-
14), a logical hypothesis is that SV promotes turnover of invadopodia, thereby increasing 
the amount of matrix holes formed.  Movies of EGFP-SV and RFP-cortactin, and/or 
RFP-SV and EGFP-MT1-MMP on gelatin could provide data on the lifetime of 
invadopodia, as well as the time of invadopodia initiation to the onset of degradation.  
Based on COS-7 cell experiments, SV causes a redistribution of cortactin to the ventral 
cell surface (Figure 2-5).  SV overexpression in MDA-MB-231 cells could similarly 
target cortactin to potential invadopodia initiation sites.  It would also be interesting to 
see the dynamics of cortactin and MT1-MMP in SV knockdown cells. The lack of SV 
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may be blocking a pathway for MT1-MMP or other MMPs to reach the ventral cell 
surface, especially under the cell center, which may become evident in real-time images.   
The recent detection of a direct interaction between SV and cortactin (Figure 2-7) 
further supports a role for SV at invadopodia.  While it requires further characterization, 
it does provide a basis for other observations.  For example, the EGFP-SV/F-
actin/cortactin punctae we observe closely resemble cortactin structures seen in 
association with endosomes (Kaksonen et al., 2000), in static images as well as their 
dynamic properties.  Thus, these actin-binding proteins (SV and cortactin) may not be 
merely playing a structural role in invadopodia formation, but may contribute to their 
function in matrix degradation through the trafficking of proteases to the cell surface.  In 
fact, secretion and surface expression of MMPs is dependent on cortactin protein levels 
(Clark et al., 2007).  Additionally, cortactin and dynamin2 regulate protein traffic from 
the trans-Golgi network (Cao et al., 2005) and the Golgi has been shown to be oriented 
toward invadopodia (Baldassarre et al., 2003).  Though the role of cortactin in promoting 
actin nucleation at invadopodia has been well studied, little is known about how cortactin 
arrives at invadopodia initiation sites.  The observation that SV redistributes cortactin to 
the ventral cell surface in COS-7 cells leads to the hypothesis that SV increases matrix 
degradation at invadopodia by increasing the efficiency of cortactin targeting.    
Consequently, SV may act in concert with cortactin to regulate exocytosis of MMPs to 
the plasma membrane for matrix degradation. 
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Membrane rafts and invadopodia 
There are many studies that support the intersection of my data involving SV at 
membrane rafts and SV at invadopodia. First, focal adhesions show a high degree of 
membrane order that depends on caveolin and integrin engagement with the ECM (Gaus 
et al., 2006).  Because podosomes and invadopodia share many components of focal 
adhesions, it is possible that membrane rafts are present in these structures and act to 
compartmentalize them from the surrounding plasma membrane.  Membrane rafts have 
been shown to positively regulate the activation of integrins (Leitinger and Hogg, 2002), 
which make the initial contact with the ECM, triggering the cascade of events leading to 
invadopodia formation (Mueller et al., 1999).  Also, inhibition of the epidermal growth 
factor (EGF) receptor, a protein long identified with membrane raft signaling (Mineo et 
al., 1996), disrupts invadopodia formation (Yamaguchi et al., 2005a).  A recent paper 
describes EGF-induced coalescence of membrane rafts of different composition, 
suggesting an ability to assemble signaling platforms (Hofman et al., 2008).   
Another overlap of membrane raft and invadopodia signaling involves Arf6 and 
MT1-MMP.  Arf6 is a small GTPase that regulates endosome membrane trafficking to 
the plasma membrane, actin remodeling and cell migration (Boshans et al., 2000; 
Palacios et al., 2001; Donaldson and Honda, 2005; D'Souza-Schorey and Chavrier, 
2006). This protein is also involved in trafficking of membrane rafts along microtubules 
to the cell surface for spreading, regulating Rac1 activation and raft recruitment 
(Balasubramanian et al., 2007). Arf6 is abundant in highly invasive breast cancer cells 
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and is required for matrix degradation at invadopodia (Hashimoto et al., 2004; Tague et 
al., 2004; Hoover et al., 2005).  In addition, the role of Arf6 in invadopodia formation is 
dependent on ERK activity (Hashimoto et al., 2004). Here, it is worth noting that the 
smooth muscle isoform of SV, SmAV, is required for stimulus-mediated contractility 
through ERK signaling (Gangopadhyay et al., 2004) and that SV co-localizes with Arf6 
in membrane tubules (E. Luna and Z. Fang, unpublished data).  MT1-MMP activity also 
promotes the sustained phosphorylation of ERK1/2 (Takino et al., 2006), and MT1-MMP 
must be released from DRM-confinement to be active (Mazzone et al., 2004).  So, it is 
likely that SV, as a component of DRM-H and its ability to activate the ERK pathway, 
works in concert with Arf6 to traffic MMPs to invadopodia for efficient matrix 
degradation.   
 In light of my data and the existing literature, I propose the following model for 
matrix degradation at invadopodia involving SV (Figure 4-1).  SV activates ERK 
signaling upstream of cortactin in a membrane raft in a recycling endosome compartment 
with Arf6.  SV facilitates exocytosis by possibly binding to microtubule motor proteins 
(T. Smith, unpublished data) to move exocytic vesicles along microtubules to 
invadopodia initiation sites, delivering MMPs in the process. The SV-cortactin 
interaction could contribute to invadopodial targeting of outgoing vesicles.  Alternatively, 
SV could be promoting cortactin trafficking to invadopodia, and cortactin subsequently 
increases MMP trafficking.   
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 The overall goal of this research was to provide a fundamental understanding of 
how invasive cells move.  Crucial to the cell’s ability to move are adhesion and invasion.  
SV and its many interacting proteins have profound effects on both of these properties.  
Ideally, the continued molecular dissection of invadopodia could lead to identification of 
promising targets for medical intervention in the metastatic spread of cancer.   
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Figure 4-1.  Model for the role of SV in degrading matrix at invadopodia. 
SV promotes ERK activation, stimulating trafficking of cortactin, Arf6, MT1-MMP and 
SV from an endosome compartment containing membrane rafts to the invadopodia 
initiation site.  This trafficking may involve microtubule (MT) motors that bind to SV 
(unpublished data).  The SV-cortactin interaction may be involved in targeting vesicles to 
the nascent invadopodia.  MT1-MMP is inactive in membrane rafts (X) and may move 
out of the raft compartment when it reaches the invadopodium. 
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Appendix A 
Supervillin/Archvillin binding partners 
This body of work explores experiments identifying supervillin and archvillin 
interacting proteins.  These experiments contributed to early understanding of SV 
function, and were published as part of two manuscripts from the Luna Laboratory (Chen 
et al., 2003; Oh et al., 2003). 
Archvillin binds F-actin and associates with membranes.   
The supervillin C-terminus displays a high degree of homology with the 
villin/gelsolin family of actin bundling/severing proteins.  However, this domain in SV 
lacks the ability to bind to F-actin (Pestonjamasp et al., 1997; Pope et al., 1998; 
Wulfkuhle et al., 1999). Instead, the SV F-actin binding activity is confined to the N-
terminus (Wulfkuhle et al., 1999). The skeletal muscle form of SV, archvillin (AV), 
differs from SV by two muscle-specific inserts in the N-terminus. The goal of these 
experiments was to determine if the muscle-specific inserts interfere with F-actin binding 
activity.   
 
Results 
Supervillin-related protein in muscle and myogenic cells  
A 250 kDa protein characteristic of mammalian muscle and myogenic cell lines 
was identified using two affinity-purified polyclonal antibodies specific for different 
sequences in the 205 kDa non-muscle SV protein (Figure A-1). The α-H340 antibody, 
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directed against the first 340 residues of human SV, specifically recognizes SV in bovine 
neutrophils (Nebl et al., 2002). This antibody also recognized SV (205 kDa) in HeLa cells 
(Figure A-1A, lane 1, asterisk) and a larger, 250 kDa polypeptide in human 50MB-1 
myoblasts (Figure A-1A, lane 2) and in hamster (Figure A-1A, lane 3) and rabbit 
(Figure A-1B, lane 1) striated muscle. Specificity of the α-H340 antibody for SV-related 
sequences in muscle was shown both by immunoblot analyses (Figure A-1A, B) and in 
immunofluorescence micrographs of human (Figure A-1C) and murine (data not shown) 
myogenic cells. The α-pepA antibody, which was previously shown to be specific for 
amino acids 900-918 in bovine SV (Pestonjamasp et al., 1997), also recognized a 250 
kDa polypeptide in rabbit skeletal muscle (Figure A-1A, lane 4), 50MB-1 myoblasts 
(data not shown) and C2C12 myoblasts (data not shown). A similarly sized, 
immunocrossreactive polypeptide in SDS-solubilized murine leg muscle was specifically 
immunoprecipitated with α-H340 antibody (Figure A-1D). After electrophoresis on 
SDS-polyacrylamide gels and electrotransfer to nitrocellulose, the immunoprecipitated 
polypeptide bound directly to α-H340 antibody and to radiolabeled F-actin (Figure A-
1D, lane 2). Finally, the cross-reactive muscle protein co-fractionated with the 
sarcolemmal proteins, dystrophin and caveolin-3, as part of a low-density plasma 
membrane fraction from rabbit skeletal muscle (Figure A-1E, light fraction). These 
results show that the muscle protein (archvillin, AV), which is consistently larger than SV 
in several species and throughout myogenic differentiation, resembles non-muscle SV in 
that these proteins contain at least two epitopes in common, bind F-actin on blot overlays 
and are associated with plasma membranes.  These predictions are supported by 
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molecular cloning, which shows that AV is a larger splice form of non-muscle SV.   
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Figure A-1. Muscle contains a 250 kDa F-actin binding protein that is related to 
supervillin. 
(A) Two antibodies (α-H340, α-pepA) against human supervillin (asterisk) recognize a 
larger protein in muscle cells (line). Immunoblots of human cervical carcinoma (HeLa 
S3) cells (lane 1), human 50MB-1 myoblasts (lane 2), hamster skeletal muscle (lane 3) 
and rabbit skeletal muscle (lane 4) were probed with affinity-purified rabbit polyclonal α-
H340 (lanes 1-3) or α-pepA (lane 4) antibodies.  
(B) Specificity of the α-H340 antibody on immunoblots. Affinity-purified α-H340 
antibody (0.5 µg/ml) was pre-incubated for 1 hour at 0-4°C without (–) or with (+) 
bacterially expressed H340 protein (60 µg/ml) before incubation with blot strips 
containing rabbit skeletal muscle (100 µg/lane) and visualization by ECL.  
(C) Specificity of the α-H340 antibody in immunofluorescence. Phase images (a,c) and 
indirect immunofluorescence micrographs (b,d) of proliferating 50MB-1 cells stained 
with affinity-purified α-H340 and secondary antibodies. To show specificity, the α-H340 
antibody used for (c) and (d) was pre-incubated with 20 µg/ml of the H340 immunogen 
for 1 hour before use. Bar, 5 µm.  
(D) Direct binding of 32P-labeled F-actin to the 250 kDa supervillin-like protein from 
mouse muscle. Immunoprecipitation with rabbit IgG (lane 1) or with α-H340 (lane 2). 
The polypeptide specifically immunoprecipitated by α-H340 IgG binds both 32P-labeled 
F-actin (top panel) and α-H340 antibody (lower panel).  
(E) Co-fractionation of the 250 kDa supervillin-like protein with dystrophin and 
caveolin-3 in the crude plasma membrane fraction from rabbit skeletal muscle 
(Ohlendieck et al., 1991). Immunoblots with antibodies against H340, dystrophin and 
caveolin-3 in a higher-density membrane fraction enriched in T-tubules and sarcoplasmic 
reticulum (lane 1, Dense) and in the low-density membrane fraction enriched in 
sarcolemmal membranes (lane 2, Light) are shown. 
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Discussion 
Archvillin binds directly to F-actin, co-isolates with dystrophin and caveolin-3 in 
low-density sarcolemmal membranes, and co-localizes with dystrophin at costameres in 
skeletal muscle.  The presence of archvillin in light membrane fractions corresponds well 
with the data we have on SV in neutrophil (Nebl et al., 2002) and COS-7 DRM-H 
(Chapter III), supporting a potential role of SV/AV at the interface of membrane and 
cytoskeleton.   
A logical hypothesis is that archvillin serves as an additional linkage between 
actin filaments and the plasma membrane at costameres, the principle adhesion structures 
along the length of the myofiber.   Although dystrophin is required for sarcolemmal 
integrity, loss of muscle function develops only over time, suggesting the existence of 
partially redundant proteins (Hoffman et al., 1987; Blake et al., 2002).  One such protein 
is the dystrophin-related protein, utrophin, but even mice lacking both dystrophin and 
utrophin exhibit superficially normal muscle function until about four weeks of age 
(Grady et al., 1997). Other possible actin-membrane linkages at costameres include 
protein complexes that contain spectrin or focal adhesion proteins, including integrin, 
vinculin and α-actinin (Stromer, 1995; Berthier and Blaineau, 1997).  In support of the 
idea of at least partial functional redundancy, costameres containing ß-spectrin and 
vinculin are retained, although frequently disarranged, in sarcolemma of the mdx mouse 
(Williams and Bloch, 1999). Conversely, loss of α- or ß-spectrin in nematodes leads to 
muscle dysfunction (Hammarlund et al., 2000; Moorthy et al., 2000), suggesting cross-
talk among muscle membrane skeleton proteins. Because archvillin contains all the 
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sequences found in supervillin, archvillin is likely to participate in the cross-talk between 
the spectrin- and focal adhesion-based membrane skeletons at costameres in muscle. 
 
SV binds myosin II by yeast two-hybrid. 
 As part of an ongoing effort to investigate the functional domains in SV, I 
generated a series of yeast two-hybrid constructs and performed screens for SV binding 
partners.  The interaction that I found between SV11-171 and nonmuscle myosin IIA was 
not surprising, based on results from simultaneous experiments using GST pulldowns.  
Nonetheless, the results from the two-hybrid assay confirmed and extended the binding 
assays to identify a specific interacting domain of myosin II.  
 
Results 
Myosin S2 was identified as a key interaction site for the supervillin N-terminus 
in an untargeted yeast two-hybrid screen of a HeLa cDNA library that was probed with a 
bait vector encoding supervillin amino acids (11-174) (Figure A-2).  Out of 108 colonies 
screened, 10 specifically interacting clones encoding human nonmuscle myosin IIA 
(MYH-9, NCBI Protein Database accession number P35579 [GenBank]) were obtained. 
These colonies supported growth on inductive, selective media and induced expression of 
β-galactosidase activity (Figure A-2A). Seven of these clones encoded amino acids 874-
1095 in human MYH-9 (Figure A-2A, B, 1), two encoded residues 874-1100 (Figure A-
2A, B, 2), and one encoded amino acids 846-1100 (Figure A-2A, B, 3). Thus, in addition 
to GST pulldown assays (Chen et al., 2003), the untargeted yeast two-hybrid screen also 
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identified sequences within myosin S2 as important interaction sites for the supervillin N-
terminus. 
 In addition to the multiple myosin II clones that were identified from the yeast 
two-hybrid screen for SV11-174, sequences were also obtained for helicase (3 clones), 
hexokinase, hepatitis B virus x interacting protein, lamin B2, and the formally 
hypothetical proteins, now identified as SIKE (suppressor of IKKε) (Huang et al., 2005) 
and transmembrane protein 106C.  These interactions have not yet been confirmed using 
other methods.   
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Figure A-2.  Myosin S2 is sufficient for SV-(1-174) binding.  
(A)  Human nonmuscle myosin IIA sequences (MYH-9, NCBI Protein Database 
accession number P35579 [GenBank]) interact with supervillin amino acids 11-174 (SV-
(11-174)) in a yeast two-hybrid assay. Yeast transformed with pHybLex/Zeo SV-(11-
174) and a plasmid encoding one of three separately identified target sequences (lanes 1-
3) or control plasmid pYesTrp2 (lane 4) were patched onto inductive, selective media 
(galactose/raffinose, Zeocin (0.3 mg/ml), -Ura, -Trp). Colonies were transferred to a 
nitrocellulose membrane and assayed for β-galactosidase activity according to the 
manufacturer's protocols (Invitrogen).  
(B)  Schematic representation of the locations of the target sequences (lines 1-3) 
identified by yeast two-hybrid screening with respect to the domain structure of human 
nonmuscle myosin IIA. All target sequences include most of the S2 domain. The smallest 
interacting sequence, amino acids 874-1095, corresponds to residues 887-1108 in chicken 
smooth muscle myosin MYHB (NCBI Protein Database accession number P10587 
[GenBank]). 
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Discussion 
The results of this untargeted yeast two-hybrid screen provides strong evidence 
that SV, in addition to being an F-actin binding protein, also binds to myosin II.  At the 
time, we were not sure if the binding was direct, as filamin was also present in GST-SV 
pulldowns of smooth muscle (Chen et al., 2003).  In addition to providing evidence for 
direct binding, these experiments narrowed down the region in myosin II in which the N-
terminal fragment of SV was binding.   
The minimal myosin S2 sequence required for binding to supervillin may lie 
between smooth muscle myosin Lys-887 and Asn-1030. The smallest myosin sequence 
identified as a strong positive in the yeast two-hybrid screen corresponds to chick smooth 
muscle myosin residues 887-1109. The prominent binding of 35S-SV-(1-174) to HMM2 in 
blot overlays (Chen et al., 2003) indicates that sequences N-terminal to Asn-1030 are 
sufficient for binding, albeit at a possibly reduced affinity. The greatly diminished binding 
to rod in blot overlays (Chen et al., 2003) supports the importance of residues at or near 
the S1-S2 junction (amino acids 849-946 (Ikebe et al., 1998)), a region of smooth muscle 
myosin II that has been suggested to play an important role in the regulation of myosin 
activity and assembly, both directly (Ikebe and Hartshorne, 1984, 1985; Konishi et al., 
2001) and through binding of regulatory proteins (Ikebe and Reardon, 1988; Kohama et 
al., 1996; Kunst et al., 2000; Morgan and Gangopadhyay, 2001; Wang, 2001).  The S2 
region of myosin II is on the surface of the myosin II thick filament, where it may 
regulate the extension and activation of the myosin II heads (Woodhead et al., 2005; 
Alamo et al., 2008; Jung et al., 2008).   
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Supervillin also may mediate the interaction between myosin II and actin 
filaments. Such a function is well accepted for other proteins known to bind to both 
myosin and actin filaments. These proteins include myosin light chain kinase, calponin, 
and caldesmon (Ikebe and Reardon, 1988; Kohama et al., 1996; Gusev, 2001; Morgan 
and Gangopadhyay, 2001; Wang, 2001). Although calponin and caldesmon have been 
investigated primarily in smooth muscle, nonmuscle isoforms for all three of these 
proteins exist. Thus, one hypothesis for the myosin II redistribution induced by 
overexpressed SV-(1-174) (Chen et al., 2003)is a dominant-negative effect caused by 
competition with other myosin S2-binding proteins. If true, then the apparently normal 
distribution of myosin II in the presence of overexpressed SV-(1-342) (Chen et al., 2003), 
a fragment that contains an actin-binding site as well as the myosin-binding site, implies 
that supervillin may organize actin and myosin filament interactions in ways similar to 
those proposed for caldesmon and calponin. The tight association of supervillin with 
liquid-ordered membrane domains (Nebl et al., 2002) and its localization at actin-rich 
membrane punctae (Wulfkuhle et al., 1999; Nebl et al., 2002)further suggest that 
supervillin is well suited to promote the recruitment of, and/or to regulate the interaction 
between, actin and myosin filaments at these regions of the membrane. As the only 
protein known so far to be capable of linking liquid-ordered membrane domains to both 
F-actin and myosin II, supervillin may be an important "adapter" protein for the 
organization of membrane skeleton attachments at these dynamic regions of the plasma 
membrane. 
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Materials and Methods 
Rabbit muscle fractions  
 Crude rabbit skeletal muscle plasma membranes were prepared from freshly 
dissected or frozen back and leg muscles by flotation through 30% (w/v) sucrose, as 
described (Ohlendieck et al., 1991). The following protease inhibitors (Sigma, St Louis, 
MO) were included in all buffers: 1 µg/ml aprotinin, 1 µM pepstatin A, 0.5 µg/ml 
leupeptin, 1 mM benzamidine, 1 µM antipain, 1 mM phenylmethylsulfonyl fluoride 
(PMSF).  Equivalent amounts of protein in the low-density fraction, which was enriched 
in plasma membranes, and in the higher-density fraction, which was enriched in 
sarcoplasmic reticulum and T-tubules, were analyzed by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) and immunoblotting.  
Muscle extracts  
 Murine hind leg muscles, or rabbit back and leg muscles, were ground under liquid 
N2 and extracted twice with 1% SDS for 10 minutes at 70°C. Extracts either were 
denatured with sample buffer for SDS-PAGE or were diluted 10-fold with 1% Triton X-
100 in PBS for immunoprecipitations. Triton X-100 extracts from ~0.3 mg muscle were 
pre-cleared for 2 hours at 4°C with rabbit immunoglobulin (RIgG) bound to protein A/G 
beads (Pierce Chemical Company, Rockford, IL) and incubated with 20 µg RIgG or α-
H340 bound to protein A/G beads for 5 hours at 4°C. Beads were washed extensively 
with PBS. Bound immunoprecipitated proteins were eluted by heating for 5 minutes at 
95°C in SDS sample buffer and analyzed by α-H340 immunoblot and F-actin blot 
overlay.  
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Immunoblots  
 Proteins were separated by SDS-PAGE (Laemmli, 1970) and electrotransferred to 
nitrocellulose (0.45 µm pore size) (Schleicher and Schuell, Keene, NH). Nitrocellulose 
blots were blocked with 5% nonfat powdered milk in TBS-T and probed with primary 
antibodies for 2 hours at room temperature or overnight at 4°C. Concentrations of 
primary antibodies were as follows: 10 µg/ml affinity-purified α-H340, 20 µg/ml α-pepA, 
5 µg/ml anti-caveolin 3 (BD Transduction Laboratories, San Diego, CA), 1:20 dilution of 
anti-dystrophin (Novocastra Lab, Burlingame, CA). Interacting polypeptides were 
visualized using either 125I-labeled protein A or protein A conjugated to horseradish 
peroxidase and an ECL substrate kit (KPL, Gaithersburg, MD). Reactive polypeptides 
were detected by exposure to Biomax-MS X-ray film (Eastman Kodak, Rochester, NY). 
For double labeling with radioactively labeled F-actin, anti-rabbit antibody conjugated to 
alkaline phosphatase was used with a BCIP/NBT substrate kit (KPL, Gaithersburg, MD) 
for colorimetric detection.  
F-actin blot overlay  
 For F-actin overlays, 125I-labeled actin was polymerized in the presence of rabbit 
gelsolin, stabilized with phalloidin and used at a final concentration of 50 µg/ml in 5% 
nonfat powdered milk in TBS-T(Luna, 1998).  In some experiments, actin was labeled 
with [α-32P]ATP (Mackay et al., 1997), using 1 mg of actin and 1 mCi of [α-32P]ATP.  
Nitrocellulose blots were exposed to film for 5 days at –80°C or to an imaging screen for 
2 hours. Signal was visualized with a Phosphor Imager SI™optical scanner and 
ImageQuant software (Molecular Dynamics, Sunnyvale, CA).  
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Yeast Two-hybrid Screens  
A bait plasmid encoding supervillin residues 11-174 was constructed and used to 
screen 1.62 x 108 clones from a library of 1.03 x 107 conditionally expressed target 
plasmids derived from HeLa S3 cDNA (Hybrid HunterTM Premade cDNA Library and 
Two-Hybrid System, Invitrogen). A cDNA encoding bovine supervillin amino acids 11-
174 was PCR-amplified using primers containing an EcoRI or SalI site (forward primer, 
5'-AGGGAATTCTTAGAAGGAATTGAAACCGACACGC-3'; reverse primer, 5'-
ATCGTCGACTATAGCCCCGAGAGCTCAGTCCT-3'). The PCR product was cloned 
into pCR2.1-TOPO® and then into the bait vector pHybLex/Zeo, in-frame with the LexA 
DNA binding domain. The bait vector (pHybLex/Zeo SV 11-174)) was transformed 
(Gietz and Woods, 2002) into yeast strain EGY48 containing the reporter plasmid 
pSH18-34. Transformants with HeLa cDNA target plasmid were screened for leucine 
prototrophy and for β-galactosidase activity on filter lifts, according to the manufacturer's 
instructions. Plasmid DNAs were isolated from positively interacting colonies (Hoffman 
et al., 1987), amplified in bacteria, and sequenced at the University of Massachusetts 
Nucleic Acid Facility (Worcester, MA). 
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Appendix B 
 
 
Detailed Protocols 
 
In this section, I provide detailed protocols and notes for assays critical to this 
dissertation. 
 
 
Preparation of gelatin coated coverslips 
 
Adapted from: 
Bowden, ET, PJ Coopman and SC Mueller, 2001.  Invadopodia: Unique methods for 
measurement of extracellular matrix degradation in vitro.  Methods in Cell Biology, 63, 
613-627. 
 
 
TRITC-gelatin:  Conjugated Type B gelatin, 225 bloom, 2.5%.  Made using above 
protocol, with following changes:  Use 10 mg of TRITC (Molecular Probes T-490) 
instead of 6 mg.  Also add Baker Bond Prepscale Abx resin (40 um, Baker #7269-00) to 
exterior dialysis solution to capture unbound dye.  Pre-mix several scoopfuls  of resin (to 
~5 ml mark) in 50 ml conical tube, cover with 1 M Tris, pH 8, mix, spin, then resuspend 
in PBS for addition to dialysis buffer.   
 
Solutions for 18 coverslips: 
 
0.5% glutaraldehyde:  312 µl of 8% glutaraldehyde 
   4.7 ml PBS 
   Make fresh. 
 
5 mg/ml sodium borohydride:  0.25 g sodium borohydride (stored at RT, desiccated) 
      50 ml PBS     
      Make fresh (usually during incubation with 
  glutaraldehyde).  
 
 
Coating coverslips: 
 
1. Pre-clean coverslips (22 x 22 mm, #1.5, or can use round 18 mm in 12 well dish) 
in 70% ethanol.  
2. Heat TRITC-gelatin (or unlabeled gelatin) in heat block to 45°C (fill well with 
water for better heating).  Allow to warm for at least 15 min. In the meantime, 
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pre-chill 0.5% glutaraldehyde/PBS on ice.  Pre-chill trays (lids of 6 well dishes) 
lined with parafilm in -20°C freezer.   
3. Remove trays from the freezer, place on ice and pipette 6 glutaraldehyde drops of 
200 µl each on tray. 
4. Using a pair of tweezers, take the coverslip at the corner and spread 200 µl of 
gelatin by tilting in a circular motion for 20 seconds.  Remove excess gelatin and 
let set for 20 seconds.  Then invert onto glutaraldehyde droplet.  Once you have 
spread gelatin on 6 coverslips, start a timer for 15 minutes.   
5. After glutaraldehyde fixation, move coverslips to 6-well dish (doesn’t have to be 
sterile, but reasonably clean).  Wash three times with PBS.   
6. Incubate with ~2 ml/well of 5 mg/ml sodium borohydride for 5-10 minutes. Air 
bubbles will form.  Tap the side of dish to ensure coverslips stay submerged. 
7. Wash 3 times with PBS.   
8. Incubate in 70% ethanol for 10 min.  Move to tissue culture hood. 
9. Rinse with PBS once or twice.  Incubate in serum-free DMEM for at least one 
hour before plating cells.  (I’ve tested this with phenol-red free media as well, 
doesn’t seem to make a difference with evenness of gelatin fluorescence.) 
10. After incubating cells for desired amount of time, fix as usual with 4% 
paraformaldehyde/PBS, permeabilize and block.  Stain as needed.  
 
Notes:   
• I routinely made 18 cs (3- 6 well dishes worth).  Start ~2.5 hours before you want to 
plate cells.  Set a timer for 3 -15 minute time points.  
• Clean coverslips the previous day.  Leave them to dry between two pieces of filter 
paper.  Alternatively, clean a lot of coverslips and leave them in a glass dish separated 
by filter paper. 
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Preparation of Protease Inhibitor Mix 
 
Inhibitor Description F. W. Amount for 10 mL 
of 1000X  
1X 
Concentration 
Aprotinin  Reversible inhibitor of 
proteolytic and esterolytic 
activity and serine proteases 
681.2 10 mg 1 µg/ml 
Antipain Reversible inhibitor of cysteine 
and serine proteases 
677.6 6.7 mg 1 µM 
ALLM Calpain inhibitor II 401.6 8 mg 2 µM 
Benzamidine Inhibitor of trypsin and trypsin-
like proteases 
156.6 1.565 g 1 mM 
E64 Irreversible cysteine protease 
inhibitor 
357.4 35 mg 10 µM 
Leupeptin Trypsin inhibitor 493.6 5 mg 1 µM 
Pepstatin A Inhibitor of aspartic proteases 658.9 6.6 mg 1 µM 
 
Mix all protease inhibitors in 10 mL of DMSO.  Dissolve and aliquot.  Store at -20°C.  
Use at 1:1000 dilution in lysis buffer.   
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Matrigel™ Invasion assay 
 
Day 1: 
 
Remove -20oC Matrigel™ inserts (BD Catalog # 354480, Matrigel, # 354578, Control), 
to new 24-well plate and bring to room temperature (~30 minutes).  Use sterile forceps to 
manipulate filters.   
 
Re-hydrate the inserts in complete medium: add 500 µl of medium to appropriate 
number of wells of a 24-well plate (special type, with slots for the inserts Falcon # 
353504).  Add the Matrigel™ inserts and a corresponding number of control inserts, then 
add 500 µl medium to tops of inserts.  Incubate at 37oC, 5% CO2 for 2 hours.  Dislodge 
any air bubbles on bottom of filters.   
 
Lift the cells with trypsin; stop reaction with complete medium and move to a conical 
centrifuge tube.  Remove a small aliquot for counting. 
 
Centrifuge at 1000 RPM for 5 minutes.  Count cells with hemacytometer. 
 
Remove as much of the medium as possible.  Resuspend cells in serum-free medium.  
Final concentration should be 1x105 cells per ml.  May need to make dilution.  First, 
resuspend at 106 cells/ml, and then make 1:10 dilution.  Mix well.  Make more than 
needed.  For example, for an experiment in triplicate, 3 ml of cells plus 0.5 ml to check 
for cell density is the minimum amount required.  Make 4 ml of dilution.   
 
Remove the medium used to hydrate the inserts.  Take care not to damage the 
Matrigel™!  Add 750 µl of growth medium (with serum) to the bottom of the wells.  Be 
sure there are no trapped air bubbles below the insert. 
 
Add 500 µl of cell solution to each insert.  Incubate in 37oC, 5% CO2 for 20 hours. 
Add 500 µl of cell solution to 6-well plate with coverslips to check for cell density. 
 
Day 2: 
 
Set up a 24 well plate (with slots) with the Diff Quick (or Hema 3 Stain Set, Fisher, #122-
911) fix and stain set and 2 large beakers with distilled water for rinsing.  (Tip:  mark side 
tabs of insert with sharpie to color code conditions.)   
 
Pre-wet a cotton swab with serum free medium and use it to scrub the top surface of the 
inserts to remove non-invading cells. (For Matrigel™ coated filters, remove 200-300 µl 
of media prior to scrubbing; this is not necessary for control filters.)  Swirl around the 
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edge then back and forth across the middle 10 times.  Do not press too hard!  Use firm, 
but gentle pressure. 
 
Immediately remove media and cell debris from insert and transfer the insert to the 
fixing solution and incubate 2 minutes.  Move to Stain 1 and Stain 2; incubate in each for 
2 minutes. 
 
Rinse each insert in distilled water (first in beaker one, then beaker two), tap off excess 
water, and place in a new plate to dry.  Move inserts to the fume hood to dry with lid off.   
 
Analysis: 
 
When dry, image on the Zeiss Axioscope with the color camera.  Flip plate with inserts 
upside down and image with 10X objective.  Using OpenLab, take 5 non-overlapping 
pictures, 4 around the edges and one in the center.  Can take all pictures for triplicate sets 
in the same file.  Save as TIFs and analyze using ImageJ software.  
 
Count cells from the Matrigel™ inserts using the Cell Counter plugin for ImageJ.   
 
For control inserts, using ImageJ: 
 
• Process: Binary: Threshold  
(Make a black and white image.  Select Threshold twice, if necessary, to get black 
cells on white.) 
• Process:  Binary:  Watershed 
(May have to wait 1-2 minutes.) 
• If there is debris on the image, remove it manually at this point using the Freehand 
selection and Delete. 
• Analyze: Analyze Particles 
To eliminate the pores from the count, use these settings:  Minimum = 900 pixels and 
Maximum = 9999999.9 (default). 
Select “Show Outlines” to be sure that actual cells are being counted. 
• Select the count numbers and areas, etc. in the Results panel.   
Copy into a separate Word document under the file name. 
 
To calculate percent invasion, ratio the average number of cells that migrated in the 
presence vs. absence of Matrigel™ to control for changes in cell motility.  Then ratio 
experimental percent invasion against the mean value obtained for control cells to obtain 
the invasion index.   
 
To check for cell density loaded on filters, fix cells on coverslips.  Take 25 pictures with 
10X phase contrast.  Count the average number of cells per field. 
 120 
 
Nucleofection of MDA-MB-231 Cells 
 
Modified from Amaxa product literature. 
 
*Notes: MDA-MB-231 cells lift easily/quickly with trypsin.  Need 1x106 cells per 
Nucleofection. 
For siRNA, use 1 µl of a 1:5 dilution of the 20 µM stock.  Use DEPC water.  
 For plasmids, use 2 µg of DNA. 
Work quickly when cells are in Nucleofection solution; time is 15 minutes before 
cell viability decreases drastically.  Do no more than 6 transfections at once. 
 Nucleofector program is X-13 or X-013. 
Nucleofector solution V: add 100 µl supplement to 450 µl solution V.   Good for 
3 months after mixing.  
 
Day 1:   
Split MDA-MB-231 cells from a T-25 flask to 2 - T-75 flasks (= 1: 6 ratio). 
Incubate 2 days at 37oC, 5% CO2.  (Want cells ~80-90% confluent on day of transfection.  
Day 3:  
Warm growth medium to 37oC and supplemented Nucleofection solution V to room 
temperature. 
Aliquot growth medium to required vessels (e.g. 10 cm dish, 6 well plate) and incubate at 
37oC, 5% CO2.  Also aliquot and incubate 500 µl medium to a 1.5 ml tube (one per 
Nucleofection). 
Prepare 1.5 ml tubes containing plasmid (2 µg) or siRNA (40 nM; see Note, above). 
Trypsinize to remove cells from flask; stop trypsin by addition of growth medium and 
transfer cells to a conical centrifuge tube.  
Remove small aliquot to hemacytometer for counting.   
Spin for 5 minutes at 1000 RPM on bench top centrifuge; count cells. 
Remove as much medium as possible and resuspend cells in PBS. 
Remove an aliquot of cells/PBS solution equal to the total number of cells you need to a 
new conical tube and centrifuge as above.  During centrifugation, label cuvettes and 
transfer pipets appropriately. 
Remove as much of the PBS as possible and resuspend the pellet in Nucleofection 
solution (100 µl per million cells). 
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Transfer 100 µl of cell solution to prepared tube containing siRNA or plasmid, mix by 
pupating, then transfer to cuvette.  Be sure there are no bubbles and that the solution is at 
the bottom of the cuvette. 
Move to the Nucleofector and take out the 1.5 ml tubes with 500 µl medium.  Align the 
slot in the Nucleofector with the tab of the cuvette.  Rotate in the cuvette, and then press 
the ‘X’ button to activate the program. 
After the beep (machine says OK), immediately add the warmed 500 µl of medium with 
the transfer pipet to the cuvette and move the cell solution to the 1.5 ml tube.  Save the 
transfer pipet for moving the cells to the growth vessels. 
Occasionally, machine will say “Weak” after Nucleofection.  I have proceeded 
with these samples and the knockdown efficiency has been acceptable.   
When all cells are nucleofected, move back to the laminar hood and aliquot the cells 
between growth vessels with pre-equilibrated medium as appropriate (usually 3-4 drops 
for 6 well dish for extraction, rest into 10 cm). 
Incubate at 37oC, 5% CO2 as follows: siRNA - 4 days; over-expression - 24 to 48 hours. 
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Deconvolution using Improvision Volocity program 
 
Obtain a Z-series that you want to deconvolve (in OpenLab liff file or a series of tiff 
files).   
 Use 0.2 µm step size for best results. 
If Z-series file contains more than one color, separate the channels into separate liff files 
or separate folders of tiffs.   
If you’re going to crop the image before deconvolution (for decreases in 
computing time), crop the file before separating colors, so that they will merge 
properly after deconvolution.  
Open the Volocity program. You will be prompted to create a new library.  You can do 
this by dragging and dropping an OpenLab liff file or a folder of tiffs into the library.   
If you want to do batch deconvolution (multiple cells or files at once), drag all 
OpenLab liff files into the library.   
 There is no save function in Volocity; the program saves the library upon closing.   
Calculate point spread function (PSF), or measure a specific PSF from point source 
beads.  
If deconvolving different colors, you need to calculate a PSF for each color (using 
command under Tools menu).   
If you’ve already done this for another file, you can copy and paste the PSF from 
one file to another. 
Make liff file or tiff files into volumes.  Highlight images, go to actions  make volumes 
(command + M keys for shortcut). 
Go under the properties option (command + I); enter the channel, µm/pixel, wavelength, 
and objective. 
For common use Leica: 25X oil 0.25452 µm/pixel, 63X oil 0.101µm/pixel, 100X 
oil 0.0635 µm/pixel. 
To deconvolve, use the iterative restoration tool.  Highlight all volumes you want to 
deconvolve (can batch deconvolve up to 6 full chip images at a time).  Must be all of the 
same channel, because you can only use one PSF (red or green) per deconvolution.  After 
selecting volumes, go to actions iterative deconvolution, choose PSF, enter ~98% 
confidence interval and 20 iterations, then deconvolve.  This is a time-consuming 
process.   
After deconvolution is complete, change the colors of the deconvolved volumes to red or 
green, as appropriate (Tools  Change colors).  Then go to actions create new image 
sequence (new window pops up).  Select both channels of a single image, drag into the 
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window (have to move simultaneously, not individually).  Select how many channels, 
time points, etc. and it will merge the red and green channels.  You can now view up and 
down in the Z direction.  
Notes: 
In XYZ viewer, the bottom plane is usually at the outside edge (e.g., the left side of the 
YZ and the top side of the XZ images). 
Can capture screen shot of XY, XZ, YZ and export as tiffs. 
Use Alt + click to zoom out of an image. 
Merge planes makes maximum point projection. 
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Preparation of DRMs from COS-7 Cells 
Solutions:  
TEB: 1% Triton X-100, 25 mM Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 
mM ATP 
TNE: 25mM TRIS, 150 mM NaCl, 5 mM EDTA  
Make a 10X solution: 
25ml 1M TRIS      
50 ml 3M NaCl      
10 ml 0.5 M EDTA 
15 ml dH20  
TNE-T Lysis Buffer:  TNE + 1% Triton X-100 
0.5 ml 10% Triton X-100    
0.5 ml 10X TNE    
4 ml dH2O  
Sucrose solutions: 
Make sucrose solutions in the buffer used for extraction (TEB or TNE).  
For 50 ml of 10% sucrose: 5 g sucrose, 5 ml 10X TNE, bring to volume with 
dH2O.  For all sucrose solutions check refractive index.  Sucrose solutions can be 
made ahead and stored at 4°C. 
Extraction Procedure: 
Notes for an efficient prep 
• Pour gels the day before running them.  Cover with buffer and store at 4°C. 
Prior to starting extraction:  
• Turn on Sorvall to 4°C and chill green adaptors  
• Chill Dounce homogenizer and PBS for rinsing cells. 
• Turn on ultracentrifuge, get to 4°C and run vacuum.  
• Label tubes and pre-weigh 1.4 g sucrose in the ~5 ml tubes. 
 
1. Put cells on ice, aspirate media, rinse twice with ice cold PBS.  On the last wash, tilt 
plate to allow PBS to collect at the bottom and aspirate.  
2. Add protease inhibitors to TNE-T then extract cells for 30 min on ice with 2 ml 
chilled TNE-T. 
3. Scrape with cell scraper.  Collect lysate in chilled Dounce homogenizer. 
4. Dounce on ice 10 strokes (avoid creating air bubbles). 
5. Remove from homogenizer and place in 2-1.5 ml tubes. 
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6. Spin out nuclei in Sorvall, SS34 rotor, with green tube adaptors (fill with water before 
inserting 1.5 ml tubes) at 4°C, 3000 RPM for 10 minutes. 
7. Take out supernatant and add to 1.4 g sucrose (in small clear plastic ~ 5 ml round 
bottom tubes used for the fraction collector).   
8. Cap tightly and move to rotator in cold room for 10-15 minutes. 
9. Check refractive index and if needed add 64% sucrose to get sample to about 50% 
sucrose. 
10. Place back on rotator and check refractive index again after 5 minutes.  
11. Prepare gradient in SW41 thin walled ultracentrifuge tube (Beckman)  
a. Add 1ml 10% sucrose. 
b. Load the following from bottom using long blunt tip needle: 3 ml 30%, 3 ml 
40%, 3 ml sample, 0.5 ml 64% sucrose. 
12. Place tubes (very carefully) in SW41Ti centrifuge buckets.  Check the weights of the 
buckets, must be within 0.01 g of each other for proper balance of centrifuge.  Use 
buffer to balance tubes when necessary.  
13. Put in chilled (4°C) ultracentrifuge, spin 16 hours 35,000 RPM (200,000 x g). 
 
Fractionation and analysis: 
1. Prepare 1 set of 2ml screw cap tubes and 2 sets of 1.5 ml tubes (numbered 1-19, with 
experimental designation) ahead of time.   
2. Carefully remove gradient from centrifuge and place on ice.   
3. Use fractionator in cold room (model 640 density gradient fractionator (Isco Inc., 
Lincoln, NE)) to fractionate into 19 samples.  
• Make sure line is clear prior to beginning (use dH2O and a syringe).   
• Run the fractionator in the forward direction before putting tube on to clear any 
air bubbles from the fluorinert.   
• Add tubes (2 ml screw-cap) to fraction collector tray.  Angle slightly so they don’t 
fall through.   
• Place centrifuge tube in appropriate size holder (black cap and white rubber 
holder).  Make sure top of tube is completely level with the rubber holder to avoid 
leaks.  Screw tightly on to fractionator.   
• Put a piece of parafilm under white foam pad prior to piercing tube. (Make sure 
needle is positioned properly for the size tube being used.  Watch your fingers!) 
• Run samples at 0.5-1 ml/min and set the volume collector to 0.6 ml. 
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• When finished (the pace of drops quicken—a sign that the fluorinert is coming 
out), switch the machine to reverse to draw the fluorinert back into the syringe for 
reuse.   
• Don’t leave machine unattended, as tube collector may stop moving or tube can 
leak. 
• When finished, clean fractionator by squirting dH2O through the tubing and 
wiping up any drops of sucrose. 
4. After fractionation (or simultaneously), transfer 150 µl of sample to 1.5 ml tube. 
5. In the last set of tubes put 25 µl of 5X SDS sample buffer and 100 µl of sample.  
Vortex, then heat samples in 70°C water bath for 10 min, then vortex, and centrifuge. 
6. Load samples onto large 6-16% gradient gel.  Run ~100-150 volts, 5-6 hours.  
Transfer overnight, at least 16 hours.  
7. With remaining 50 µl of sample, make a dot blot to check for GM1 levels, determine 
protein concentration using BCA assay, and measure refractive indices.  
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